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ABSTRACT OF THE DISSERTATION
Molecular Mediators of Acute and Chronic Itch in Mouse and Human Sensory Neurons
by
Manouela Vesselinova Valtcheva
Doctor of Philosophy in Biology and Biomedical Sciences
Neurosciences
Washington University in St. Louis, 2018
Professor Robert W. Gereau, IV, Chair

Itch is a distinct sensation that arises from the activation of small-diameter pruriceptive
nerve fibers innervating the skin. Recent strides in the field have identified several histaminedependent and -independent pruriceptive pathways and receptors that contribute to acute and
chronic itch. The work presented in this thesis further investigates the molecular mechanisms
involved in the signaling, development, and sensitization of itch in mouse and human. Most
pruritogen receptors are Gq-Protein Coupled Receptors (GqPCR), which canonically activate
protein kinase C (PKC); however, little is known about whether specific PKC isoforms regulate
itch. The first study in this thesis demonstrates that the isoform PKCδ contributes to histamineinduced scratching, but not histamine-independent itch. Our studies show that PKCδ is expressed
in dorsal root ganglia (DRG), where it mediates sensory neuron responses to histamine.
To investigate the mechanisms behind a common form of chronic pruritus, the second
study in this thesis applied a mouse model of dry skin itch to test changes in sensory neuron
structure and function. We found that dry skin was marked by a significant increase in epidermal
nerve fiber innervation independent of scratching. Furthermore, dry skin was associated with a
selective increase in non-peptidergic, Ret-positive fibers and a functional expansion of the
proportion of chloroquine-sensitive neurons. Epidermal hyperinnervation and increased growth
factor levels in the skin of patients with pruritic skin diseases suggest a potential role for
ix

neurotrophic factors (NTFs) in itch. In our third study, we tested the hypothesis that NTF signaling
modulates pruritogen-evoked itch. Pretreatment with nerve growth factor (NGF) selectively
potentiated histamine-induced scratching and increased the proportion of histamine-responsive
sensory neurons. Artemin pretreatment, on the other hand, potentiated scratching induced by
chloroquine, and increased the proportion of chloroquine-responsive neurons. Interestingly,
aberrations in endogenous TrkA-NGF signaling significantly impacted normal pain sensation, but
did not play a role in histamine- and chloroquine-induced itch.
In the final study of this thesis, we developed a protocol to surgically extract human DRG
from organ donors and culture dissociated human primary sensory neurons. Using this approach,
we performed functional studies to characterize the pruritogen- and algogen- responsive sensory
neuron subpopulations in humans. We found that NGF and artemin pretreatment did not change
histamine and chloroquine responses in vitro, indicating a potential functional difference between
mouse and human sensory neurons.
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Chapter 1
Introduction

1

The clinical burden of itch
Itch, or pruritus, is a sensation that arises from small diameter nerve fibers innervating the
skin and mucosa [1]. Normally, itch is an unpleasant sensory and emotional experience that
evokes the desire to scratch, thus providing the necessary drive to avoid actual or potential skin
damage. But if it becomes pathological, itch can lead to severe skin injury and emotional distress.
Chronic pruritus, defined as itch that lasts longer than 6 weeks, affects more than 15% of the
world’s population and can lead to sleep disturbances, severe anxiety, self-mutilation, and
impaired overall quality of life that may be comparable to chronic pain conditions [2-4]. Major
causes of chronic pruritus include dermatological diseases such as atopic dermatitis and
psoriasis, where itch is reported by more than 70% of patients [4-7]. Neuropathic causes of
chronic pruritus include conditions such as post-herpetic neuralgia and notalgia paresthetica [8].
Systemic diseases such as HIV, uremia due to kidney failure, cholestasis due to liver failure, and
lymphomas are also associated with a high prevalence of itch [4, 9, 10]. Drug-induced pruritus
presents as a side effect of the anti-malarial drug chloroquine, and more commonly the epidural
application of opioids [11-13]. Psychogenic pruritus is another cause of chronic itch, but remains
poorly characterized in the general and psychiatric populations [8].
Recent advances in basic and clinical research have begun to uncover some of the
molecular mechanisms underlying pathological itch, though much remains unclear, and the
current treatment options for patients with chronic pruritus are limited in number and efficacy [3,
14]. First-line treatment often consists of topical remedies such as emollients, topical anesthetics,
or coolants, and over-the-counter antihistamines, although clinical data on their efficacy is limited.
Itch secondary to skin disorders is often associated with substantial skin inflammation and
infiltration by immune cells, and can respond to immunomodulatory treatments including
corticosteroids and biologics such as TNF-alpha or interleukin blockers [3]. Neuropathic and
systemic itch may respond to neuro-modulatory medications such as gabapentin and pregabalin,
selective serotonin-reuptake inhibitors (SSRIs), or mu-opioid receptor antagonists. However,
2

uremic and cholestatic pruritus respond best to resolution of the systemic insult by kidney or liver
transplant. Ultimately, there is no magic bullet for the treatment of chronic pruritus. Many of the
available therapies provide only limited relief and are associated with significant side effects,
further underlining the importance of research to expand the current understanding of pruriceptor
physiology and identify novel potential treatment targets.

The neurobiology of itch
Primary sensory nerve fibers can be broadly categorized into three groups: fastconducting myelinated Aβ fibers, thinly-myelinated Aδ fibers, and slow-conducting unmyelinated
C fibers. Pruriceptors, much like nociceptors, consist of a subpopulation of small diameter C-fibers
and some Aδ fibers that innervate the epidermis and upper part of the dermis [1, 15, 16].
Microneurography studies in humans have been particularly useful for identifying subtypes of itchsensitive fibers as they allow researchers to directly correlate sensory fiber activation with the
reported perceptions of itch and pain by human subjects in real time. Early studies by Handwerker
and Schmelz discovered that superficial skin application of the well-known pruritogen histamine
activated a population of C-mechano-insensitive fibers, as well as a population of C-mechanoheat sensitive fibers [17-19]. These histamine-sensitive fibers responded to other inflammatory
compounds known to sensitize nociceptors, including prostaglandin-E2 and serotonin, and most
were also responsive to capsaicin [19]. While histamine plays a key role in allergic and whealand-flare reactions, many forms of clinically-relevant itch appear to work via histamineindependent mechanisms. Microneurography studies using the spicules of cowhage (mucuna
pruriens) have demonstrated another distinct subset of C-mechano-sensitive nociceptive fibers
that are activated to produce histamine-independent pruritus [20, 21].
In the skin, pruriceptive signals are transduced at the peripheral terminals of sensory
neurons whose cell bodies are located within dorsal root ganglia (DRG) or trigeminal ganglia (TG).
Information is then relayed via central projections which synapse onto cells in lamina I and II of
3

the spinal cord dorsal horn or spinal trigeminal nucleus in the brain stem, where peptide signaling
through the gastrin-related peptide receptors (GRPR) and B natriuretic peptide (BNP) receptor
NPRA play a key role [1, 22-24]. Pruriceptive information is then relayed contralaterally via distinct
subsets of spinothalamic tract neurons that project to nuclei within the thalamus, and
subsequently to higher cortical structures [25-28].

Although the itch neuraxis shares the

neuroanatomical structure of pain processing, the mechanisms behind the transmission of these
two distinct sensations are still under investigation.

Itch receptors at the primary afferents
Histamine is perhaps the most well-known and widely-studied pruritogen, but also plays
prominent physiological roles in sleep-wake cycles, vasodilation, gastric acid secretion, and
immune cell function. Histamine receptors are G protein-coupled receptors that can be classified
into four subtypes (H1-4) and can be found throughout the nervous system and many nonneuronal tissues. H1R is the main histamine receptor expressed on primary afferents, but can
also be found in neurons in the central nervous system (CNS), smooth muscle cells, and
endothelial cells [29-31]. H2R is expressed in many cell types, including gastric parietal cells
where it is a key mediator of gastric acid release. H3R couples mainly to Gαi/o and acts as an
autoreceptor throughout the nervous system [30]. H4R is also coupled to Gαi/o and has a major
role in regulating immune cell function, but whether it has a role in the nervous system remains
under investigation [32, 33]. Studies using highly selective pharmacological antagonists have
demonstrated that H1R is the main receptor responsible for itch sensation and axon reflex
neurogenic vasodilation that results in the wheal and flare induced by histamine skin prick [34,
35]. Although H4R has not been investigated as extensively in humans, preclinical studies
demonstrate that H4R antagonists were also able to reduce histamine-induced scratching in mice
[3, 36-42]. Functional studies of sensory neurons utilizing ratiometric fluorescent calcium
indicators demonstrate that histamine activates 10-15% of rodent DRG neurons [43-45].
4

Recent studies have identified several histamine-independent itch pathways that signal
through receptors in the mas-related G protein receptor (MRGPR) family. This is a diverse family
of receptors, consisting of the conserved subfamilies D to G, and several subfamilies found only
in rodents (A, B, C, and H) or primates (X). Initial studies found that most MRGPR subtypes are
expressed almost exclusively in a small subset of sensory neurons that bind the plant lectin
isolectin B4 (IB4) [46]. A key study using Mrgpr cluster knock-out mice, which lacked most MrgprA
and MrgprC genes, found that despite normal pain sensation, itch responses to chloroquine were
greatly reduced. Chloroquine is an anti-malarial drug that induces robust itch in mice and can
induce itch in humans of African descent [13]. Experiments in heterologous cells found that
chloroquine asserts its effects by activating the MrgprA3 receptor [47]. Chloroquine-responsive
DRG neurons were found to comprise a very small subset of sensory neurons (approximately
5%), and also responded to histamine and the transient receptor potential (TRP) channel V1
agonist capsaicin. The same group also found that MrgprC11 is a receptor expressed in a subset
of the MrgprA3-positive cells and is activated by the peptides SLIGRL and bovine adrenal medulla
8-22 pepetide (BAM8-22) to induce itch in rodents [48].
As mentioned previously, MRGPRX subfamily receptors are found exclusively in primates
and in humans they are mostly restricted to DRG and TG tissues. Studies using heterologous
systems demonstrate that MRGPRX1 can be activated by the peptides BAM8-22 and BAM1-22
[49, 50]. MRGPRX1 can also be activated by chloroquine, though at a much higher EC50 [47].
BAM8-22 injection induced itch along with a stinging sensation in human volunteers, supporting
a role for MRGPRX1 in the signaling of itch in humans [51]. While MRGPRX1 is not a true human
ortholog of MrgprC11 or MrgprA3, it may play a key role in the signaling of non-histaminergic itch
in humans. MRGPRX2 RNA has been identified in both DRG and mast cells, though its potential
role in itch remains unknown [52-55]. No ligands have been described yet for MRGPRX3 and 4
subtypes, but a study overexpressing MRGPRX3 under the β-actin promoter in rat found several
skin and eye abnormalities [56, 57].
5

MrgprD is another pruritogen receptor subtype that is conserved in rodents and primates,
and is found specifically in non-peptidergic C-fiber nociceptors that synapse onto lamina II
neurons of the spinal cord dorsal horn [58]. A subset of MrgprD-positive neurons can be activated
by β-alanine, an amino acid commonly found in muscle building supplements, to induce itch in
both mice and humans [59]. Some MrgprD-positive neurons are also heat- and mechanosensitive, but the complexities of this subpopulation are not yet well characterized [60-62]. In
addition to the histamine and Mrgpr family receptors, various other itch receptors have been
discovered, including proteinase-activated receptors (e.g. PAR2), toll-like receptors (TLR7),
interleukin receptors (IL-31), and thymic stromal lymphopoetin receptor (TSLPR) [63].
The expression pattern of pruritogen receptors identifies at least three functionally distinct
subtypes of pruriceptive fibers (Fig. 1) [64-66]. Calcium imaging studies have identified a
histamine-responsive subgroup (Fig.1A) and a β-alanine-responsive group (Fig. 1B), representing
two distinct subpopulations that do not respond to other pruritogens [43, 47, 59, 67-69]. The third
pruriceptor subtype is a chloroquine-responsive group, representing only 5-10% of sensory
neurons. This group includes all SLIGRL/BAM8-22 responsive neurons. In addition, more than
half of all chloroquine-sensitive neurons also respond to histamine (Fig. 1C). Interestingly,

Figure 1. Subtypes of pruriceptive fibers. A. Histamine-responsive subset of
pruriceptors is functionally linked to TRPV1. B. β-alanine-responsive cells are a
distinct subset of MrgprD+ non-peptidergic neurons. C. MrgprA3-expressing
neurons are both TrkA/Ret+ and represent a subset of pruriceptors that can
respond to a number of pruritogens.
6

ablation of MrgprA3-positive neurons had no effect on pain behavior, but caused profound deficits
in scratching induced by chloroquine, SLIGRL, BAM8-22, and in models of dry skin and allergic
contact dermatitis [70]. Histamine-induced scratching was reduced to a lesser extent, likely due
to the remaining histamine-specific subpopulation (Fig 1A). These studies suggest that the
MrgprA3-positive population of chloroquine-responsive neurons may be particularly tuned for
sensing itch.

Intracellular mediators of itch
The majority of recently identified pruritogen receptors are Gq protein-coupled receptors
(GqPCRs), which exert their physiological effects via protein kinase C (PKC) activation and
release of intracellular calcium stores [63, 64, 71]. The specific signaling cascades immediately
downstream of pruritogen receptor activation remain less clear. Sensory neuron activation via
H1R appears to be dependent on PLCβ3, as demonstrated by the findings that PLCβ3 knock-out
mice scratch less when injected with histamine and almost all DRG calcium responses to
histamine are ablated [43]. However, this study also found that over 85% of IB4-positive neurons
and more than 30% of peptidergic neurons expressed PLCβ3, posing the question of what
mechanisms confer specificity to histaminergic signaling.
The canonical PLC pathway generates inositol triphosphate (IP3) and diacylglycerol
(DAG), which act to release intracellular calcium stores and activate downstream targets,
respectively. Gq protein-coupled receptors induce PKC activation via the generation of DAG and
release of intracellular calcium stores [72]. Several PKC isoforms are expressed in sensory
neurons [73-75] and are known to directly modulate ion channels, pointing to one possible mode
of regulation of itch signaling [75-77]. The novel PKC subtype PKCδ depends on DAG for
activation and is found in sensory neurons [72, 73, 78, 79]. PKCδ does not play an important role
in acute pain behavior but was demonstrated to be involved in CFA-induced thermal hyperalgesia
- a TRPV1-dependent process [80]. Furthermore, studies of histamine-induced signaling in
7

human aortic endothelial cells (HAECs) and HeLa cells (all of which express H1R endogenously)
demonstrate that PKCδ is phosphorylated in response to histamine [81, 82]. PKCδ also appears
to be important for histamine-induced H1R mRNA up-regulation and activation of ERK1/2 and
p38 [81, 82].

In chapter 2, we investigate whether PKCδ plays a role in the signaling of

histaminergic and histamine-independent itch.
Several studies indicate that pruritogen receptors are functionally linked to specific
transient receptor potential (TRP) channels, a family of non-selective cation channels that can be
activated by diverse environmental and physiological stimuli [83-87]. Early microneurography
studies in humans demonstrate that most histamine-sensitive fibers respond to heat, suggesting
the expression of the heat-sensitive channel TRPV1 [17, 19]. In vitro animal studies confirmed
this, demonstrating that 30-60% of histamine-responsive sensory neurons can also be activated
by the TRPV1 agonist capsaicin [47, 68, 86, 88]. TRPV1 deletion and pharmacological inhibition
significantly reduced histamine-evoked scratching and sensory neuron responses to histamine,
indicating a functional link between histamine receptor and TRPV1 [88, 89]. TRPV1 is also
expressed in other subsets of pruriceptors, including MrgprA3- and MrgprC11-positive neurons,
but it does not appear to play a functional role in histamine-independent itch [47, 48, 68, 86, 89,
90].
Several findings indicate that histamine-independent itch is instead mediated by TRPA1,
a promiscuous TRP channel activated by a number of environmental irritants. The TRPA1 agonist
mustard oil (MO) activates a large proportion of CQ- and BAM8-22-responsive neurons [68, 86,
90]. Both genetic deletion and pharmacological inhibition of TRPA1 significantly reduced
scratching responses and neuronal activation by chloroquine and BAM8-22 [90, 91]. Interestingly,
it appears that the Mrgpr receptors engage different mechanisms to activate TRPA1, where
MrgprA3 signals via Gβγ, while MrgprC11 signals through PLC [90]. TRPA1 also mediates chronic
itch and oxidative stress-induced itch, further demonstrating its role in histamine-independent
mechanisms of pruritus [90, 92, 93].
8

Differentiating between itch and pain
Itch and pain are two distinct sensory experiences. The prototypical behavioral response
that inhibits itch is a noxious stimulus in the form of a scratch. Conversely, inhibition of pain by
epidural anesthetics is frequently associated with itch. The polymodal nature of pruriceptive
neurons has given rise to two major competing theories regarding the physiological basis of itch.
The first, known as “the intensity theory”, postulates that itch arises from the same population of
neurons that signal pain. It hypothesizes that stimulus intensity determines whether a stimulus is
perceived as “itchy” or painful, with the expectation that a low-intensity noxious stimulus produces
itch. The alternative, “labeled-line theory” proposes that itch- and pain-sensitive pathways are
anatomically separate and specialized for transducing only one sensation.
Recent studies of the molecular mechanisms that mediate itch and pain have uncovered
evidence to support the labeled-line theory. Even though pruriceptors resemble nociceptors in
their ability to respond to painful stimuli like heat and chemical irritants, a recent finding
demonstrates that selective activation of pruriceptive neurons results in itch, not pain. In an
elegantly designed study, Han et al. used TRPV1 global knock-out mice engineered to express
TRPV1 solely in the MrgprA3-positive subset of neurons. In these animals, cheek application of
the TRPV1 agonist capsaicin induced itch-specific scratching instead of the nociceptive wiping
response induced by capsaicin in wild type controls [70]. These results demonstrate that the
selective activation of MrgprA3-positive neurons specifically transduces itch and further support
the idea that pruriceptors are a distinct subset of sensory neurons specialized for sensing itch.
Even so, psychophysical studies in humans have demonstrated that the sensation experienced
after application of the pruritogens histamine, BAM8-22, or β-alanine may not be a true pure itch,
as participants report it is frequently accompanied by prickling or burning undertones, suggesting
more complex underlying mechanisms.

9

Development and sensitization of pruriceptors
Primary afferents are pseudounipolar neurons derived from neural crest cells that migrate
out of the neural tube and differentiate into a heterogeneous pool of proprioceptors,
mechanoreceptors, thermoreceptors, nociceptors, and pruriceptors [94, 95]. The survival and
phenotype specification of these functionally distinct groups is regulated by transcription factors
and neurotrophic factors. Nerve growth factor (NGF) signals via the receptor tyrosine kinase A
(TrkA) to support the survival of small diameter sensory neurons during embryogenesis [96-103].
Those neurons which retain TrkA expression into adulthood become the peptidergic subset
known for their expression of calcitonin gene-related peptide (CGRP) and substance P [100, 104,
105]. However, about half of small diameter neurons downregulate TrkA in the early post-natal
period and begin to express the receptor tyrosine kinase Ret [104, 106]. This subset is dependent
on the glial cell line-derived neurotrophic factor (GDNF) family ligands (GFLs) GDNF, neurturin
(NRTN), and artemin (ARTN). Ret activation by the GFLs requires a cell surface co-receptor
known as GDNF Family Receptor α (GFRα). Analysis of GFL and co-receptor null mice
demonstrates highly restricted physiological pairing of ligand and high affinity co-receptors in vivo:
GFRα1/GDNF, GFRα2/NRTN, and GFRα3/ARTN [107, 108]. The small diameter Ret-positive
neurons constitute the non-peptidergic subset of nociceptors, which are largely identified by their
ability to bind the plant lectin isolectin B4 (IB4). Additionally, neurotrophic factor signaling via TrkA
and Ret is necessary for the establishment of peripheral target innervation during development
and the maintenance of innervation throughout adulthood [101, 109, 110]. The expression of TrkA
and Ret determine neuronal dependence on different neurotrophic factors, contributing to the
development and maintenance of anatomically and functionally distinct populations of sensory
neurons.
Sensory nerve fibers in the skin are in close proximity to keratinocytes, dermal fibroblasts,
and immune cells, which can release pruritogens, various pro-inflammatory mediators, and
neurotrophic factors (NTFs) [1, 111-119]. Studies have identified multiple mechanisms by which
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inflammation and growth factors directly activate and sensitize nociceptors in the context of pain.
NGF and the GFLs have been shown to directly sensitize and upregulate the expression of
TRPV1 and TRPA1 [120-125]. Overexpression of select growth factors in keratinocytes results in
epidermal hyperinnervation, sensory neuron cell body hypertrophy, and enhanced expression of
TRP channels, which contributes to a state of hyperalgesia [126-130]. In addition, neurotrophic
factors regulate the expression and function of sodium channels, which directly contribute to the
regulation of nociceptor excitability [131-135]. In conclusion, these findings indicate a clear role
for neurotrophic factors in the sensitization of pain, but whether and how they directly affect
pruriceptors remains unknown.
Several key observations suggest that neurotrophic factors could contribute to chronic
itch. First, epidermal hyperplasia and inflammatory cell infiltration are hallmarks of many pruritic
skin diseases, serving as a source of increased neurotrophic factor levels. Studies of atopic
dermatitis and psoriasis have shown that the severity of itching correlates with increased serum
levels of NGF [136-139]. Lesional skin from atopic dermatitis patients is marked by increased
levels of NGF in the skin and increased TrkA in epidermal nerve fibers [137-140]. Another recent
study found that artemin is also increased in the skin of patients with atopic dermatitis [141].
Epidermal hyperinnervation of lesional skin is another common feature of pruritic skin diseases
that suggests neurotrophic factor involvement [140, 142, 143]. Co-culturing human keratinocytes
from patients with atopic dermatitis with porcine sensory neurons resulted in increased local NGF
release and greater axon growth when compared to a co-culture using healthy human
keratinocytes [144]. NGF and TrkA inhibition in a mouse model of atopic dermatitis reduced both
scratching and epidermal fiber density [145, 146]. Human TrkA deficiency results in congenital
insensitivity to both pain and itch, confirming that NGF-TrkA signaling plays a key role in the
development and maintenance of pruriceptors [147].
Acutely, intradermal injection of NGF in human subjects enhanced itch produced by the
non-histaminergic pruritogen cowhage [148]. In a Phase II clinical study investigating artemin as
11

a potential treatment for unilateral sciatica, the most commonly reported adverse reactions to
intravenous or subcutaneous artemin administration were changes in temperature perception and
pruritus [149, 150]. In animal studies, artemin treatment induced warmth-provoked scratching
behavior that was dependent on the expression of the artemin co-receptor GFRα3 [141]. Finally,
neurotrophic factors can directly induce mast cell degranulation, stimulating local histamine
release to induce itch [151-154]. These findings suggest that NTFs regulate itch, but the
mechanisms of this modulation are poorly understood.
Immunohistochemical characterization of pruriceptive neurons suggests a potential role
for both NGF-TrkA and GFL-Ret signaling in the regulation of pruriceptor physiolgy. Histamineresponsive neurons co-express TRPV1 and their activation results in the axon-reflex vasogenic
reaction, suggesting they express peptides, likely making them TrkA-positive. On the other hand,
Ret is expressed in both the β-alanine- and chloroquine-responsive subsets of pruriceptive
neurons (Fig 1B-C) [58, 70]. Interestingly, the MrgprA3-positive group was also found to express
CGRP, indicating that MrgprA3 pruriceptors represent a small subpopulation of neurons that have
retained both peptidergic and non-peptidergic markers [70]. In chapter 4 of this manuscript, we
investigate the role of both NGF and the GFLs GDNF, neurturin, and artemin in histamine- and
chloroquine-evoked itch.

Translational approaches to preclinical studies of itch and pain
For decades, animal models have been the backbone of preclinical research. Studies
using mice provide key advantages, most notably precise genetic manipulation and quick
breeding, that allow thorough hypothesis testing in a complex biological system. As an in vitro
model, primary cultures of dissociated rodent sensory neurons have been used to study pain,
itch, nerve injury, regeneration, and axonal transport. Many candidate molecular targets and
genes have been identified using this approach, yet few of these findings have directly translated
into effective and safe clinical treatments [155-159]. Several notable failures in translation suggest
12

prominent differences in fundamental biological mechanisms between humans and rodents [160166]. MrgprA3 and MrgprC11 pruriceptor physiology is one important example of fundamental
receptor differences between species. Due to divergent evolutionary mechanisms, these receptor
families are greatly expanded in the mouse, but are not found in primates. While the human
MRGPRX1 receptor can be activated by the same agonists, key differences in receptor structure
and pharmacology demonstrate that these receptors are not true orthologs [47, 48, 70, 167]. In
addition, the functional link between mouse MrgprA3 and C11 receptors and TRPA1 may not be
present in primates. Studies using heterologous expression models suggest that MRGPRX1 may
actually engage TRPV1 as a downstream mechanism for cell activation [167, 168]. Thus, key
differences in the molecular mechanisms underlying human and rodent sensory neuron
processing demonstrate the importance of preclinical target validation in human cells [169-172].
A major obstacle impeding the validation of basic research findings is access to human
tissues. Human neurons are notoriously difficult to obtain and maintain in culture for use in
experiments. That is most likely the reason why very little is currently known about the physiology
of human pruriceptive subpopulations. In the final study in this dissertation, we describe a protocol
we developed for the surgical extraction of human dorsal root ganglia from deceased organ
donors. This approach has provided us with access to human tissue with a minimal post-mortem
interval, allowing the successful culturing of human sensory neurons. In chapter 5, we
characterize the human pruriceptive subpopulations that respond to histamine and chloroquine,
and directly test the effects of neurotrophic factors on pruriceptor calcium responses.
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Abstract
Itch-producing compounds stimulate receptors expressed on small diameter fibers that
innervate the skin. Many of the currently known pruritogen receptors are G q-Protein Coupled
Receptors (GqPCR), which activate Protein Kinase C (PKC). Specific isoforms of PKC have been
previously shown to perform selective functions; however, the roles of PKC isoforms in regulating
itch remain unclear. In this study, we investigated the novel PKC isoform PKCδ as an intracellular
modulator of itch signaling in response to histamine and the non-histaminergic pruritogens
chloroquine and β-alanine. Behavioral experiments indicate that PKCδ knock-out (KO) mice have
a 40% reduction in histamine-induced scratching when compared to their wild type littermates.
On the other hand, there were no differences between the two groups in scratching induced by
the MRGPR agonists chloroquine or β-alanine. PKCδ was present in small diameter dorsal root
ganglion (DRG) neurons. Of PKCδ-expressing neurons, 55% also stained for the non-peptidergic
marker IB4, while a smaller percentage (15%) expressed the peptidergic marker CGRP. Twentynine percent of PKCδ-expressing neurons also expressed TRPV1. Calcium imaging studies of
acutely dissociated DRG neurons from PKCδ-KO mice show a 40% reduction in the total number
of neurons responsive to histamine. In contrast, there was no difference in the number of
capsaicin-responsive neurons between KO and WT animals. Acute pharmacological inhibition of
PKCδ with an isoform-specific peptide inhibitor (δV1-1) also significantly reduced the number of
histamine-responsive sensory neurons. Our findings indicate that PKCδ plays a role in mediating
histamine-induced itch, but may be dispensable for chloroquine- and β-alanine-induced itch.
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Introduction
Itch, clinically known as pruritus, is an unpleasant sensory and emotional experience that
leads to the desire to scratch [1, 2]. Chronic itch can result in severe anxiety, self-mutilation, and
impaired overall quality of life that is comparable to chronic pain [3-5]. Several histaminedependent and histamine-independent itch receptors have been recently identified; however, few
of the intracellular mediators downstream of these receptors have been characterized. Elucidating
the intracellular mediators that activate pruriceptors may provide a new set of targets to aid in the
generation of more specific and efficacious treatments.
Intradermal histamine induces itch via direct activation of the H1 histamine receptor, which
is expressed in sensory neurons [6-10]. Additionally, several subtypes of the recently
characterized class of Mas-related gene protein receptors (Mrgpr) have been shown to respond
selectively to a variety of non-histaminergic, itch-producing compounds. For example, MrgprA3 is
activated by the anti-malarial drug chloroquine (CQ) [11, 12], and β-alanine induces itch by
activating a subset of nonpeptidergic MrgprD-expressing sensory neurons [13, 14].
A common property of many of the identified pruritogen receptors, including the H1
histamine receptor (H1R), MrgprA3, and MrgprD, is that they are Gq-protein coupled receptors
(GqPCRs) [10-12, 14]. Canonically, GqPCRs activate phospholipase C (PLC), which cleaves
phosphatidylinositol (PIP2) into inositoltriphosphate (IP3) and diacylglycerol (DAG), resulting in
release of intracellular calcium stores and activation of downstream targets. However, the itchmediating factors downstream of PLC are largely unknown [10, 15]. Protein kinase C (PKC) is
coupled to the canonical GqPCR/PLC pathway via activation by DAG and/or calcium and therefore
may play a role in the signaling of itch.
A number of PKC isoforms are expressed in sensory neurons [16-19]. One of these
isoforms is PKCδ, a member of the “novel” PKC isozymes, which depends on DAG but not
calcium for its activation. Previously, we demonstrated that PKCδ is dispensable for withdrawal
responses to acute noxious mechanical and thermal stimuli [20]. However, studies of H1R
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signaling in human aortic endothelial cells and HeLa cells showed that PKCδ is phosphorylated
in response to histamine [21, 22]. PKCδ also mediated histamine-induced H1R mRNA
upregulation and downstream activation of ERK1/2 and p38 [21, 22]. These lines of evidence
suggest that PKCδ could play a specific role as an intracellular modulator of itch in sensory
neurons.
In this study, we tested the hypothesis that PKCδ contributes to pruritogen-induced itch.
We determined the role of PKCδ in histaminergic and non-histaminergic itch by examining
scratching responses to histamine and the non-histaminergic pruritogens chloroquine and βalanine, which activate separate pruriceptor subpopulations. We characterized the distribution of
PKCδ in sensory neurons and show that both genetic deletion and pharmacological inhibition of
PKCδ significantly decrease the proportion of histamine-responsive neurons.
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Materials and Methods
Subjects and ethical approval
All experiments were conducted in accordance with the National Institute of Health guidelines
and received the approval of the Animal Care and Use Committee of Washington University
School of Medicine. Eight to twelve-week old male littermate mice were housed on a 12 hour lightdark cycle and allowed ad libitum access to food and water.
PKCδ-KO mice were obtained from Dr. Michael Leitges [23]. These mice were generated
using a standard gene targeting approach to insert a LacZ/neo cassette in the first transcribed
exon of the PKCδ gene to abolish transcription, resulting in a global knock-out [23]. PKCδ-KO
mice were backcrossed on a C57BL/6 background for at least 6 generations prior to use. PKCδKO mice were then crossed with wild type C57BL/6 mice to generate heterozygous mice, which
were used to generate wild type and KO littermates.

Pruritogen-induced scratching behavior
The nape of the neck and upper back were shaved with electric clippers one day prior to
behavioral experiments. On the day of experiment, mice were placed in individual plexiglass
observation boxes and allowed to acclimate in the presence of white noise for 2 hours. Using
gentle restraint, 50μl consisting of pruritogen dissolved in 0.9% normal saline was injected
intradermally at the nape of the neck using a 29½ gauge insulin syringe. The following pruritogen
amounts were used: 1mg histamine (Sigma Aldrich, St. Louis, MO), 200μg chloroquine (Sigma
Aldrich, St. Louis, MO), and 223μg β-alanine (Sigma Aldrich, St. Louis, MO). A single scratch bout
was defined as one or more rapid back-and-forth motions of the hindpaw directed at the injection
site, ending with either a pause, licking, or biting of the toes or placing of the hindpaw on the floor.
Scratch bouts by the hind-paw directed at the injection site were counted over a period of 30
minutes. Experimenters were blinded to mouse genotype.
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PKCδ immunohistochemistry and Western Blotting
For Western blotting, mice were euthanized by swift decapitation and lumbar spinal cord and
lumbar DRG were removed. Tissue samples were homogenized in homogenization buffer (20mM
Tris-HCl, ph7.4, 1mM EDTA, 1mM sodium pyrophosphate, 25μg/ml aprotinin, 25μg/ml leupeptin
and 100μM phenylmethylsufonyl fluoride) on ice. 7μg of spinal cord and DRG protein were
separated using 4-12% SDS-PAGE, then transferred to nitrocellulose membrane. Membrane was
blocked in Odyssey blocking buffer for 1 hour, then incubated in rabbit anti-PKCδ (1:1000, Santa
Cruz) and mouse anti-β-Tubulin (1:1000, Sigma-Aldrich) primary antibodies in Odyssey buffer
with 0.1% Tween-20 at 4°C overnight. Blots were then washed in TBS-0.1% Tween-20, and
incubated for 1 hour at room temperature in secondary antibodies (goat anti-rabbit Alexa Fluor
680 (1:20,000, Sigma Aldrich); goat anti-mouse IR800 (1:20,000, Sigma Aldrich)). Blots were
washed and scanned using an Odyssey infrared scanner.
For immunohistochemistry (IHC), mice were deeply anesthetized with a ketamine, xylazine,
and acepromazine cocktail, then perfused intracardially with cold PBS followed by 4%
paraformaldehyde in PBS. Lumbar DRG were removed and cryoprotected in 30% sucrose.
Transverse sections were cut at 18μm thickness on a cryostat and collected on slides. To
determine the percentage of total neurons that express PKCδ, dual labeling was performed with
rabbit anti-PKCδ (1:50, Santa Cruz) and mouse anti-β-tubulin (1:1000, Sigma Aldrich) primary
antibodies. Briefly, sections were blocked in 2% BSA, 0.1% Milk powder, 0.05% Tween-20 TBS
for 1 hr, then incubated in primary antibodies overnight at 4°C. On day 2, slides were washed and
incubated in secondary antibodies for 2-4 hours at 4°C (Alexa Fluor 488 Donkey anti-rabbit 1:200,
Alexa Fluor 555 donkey anti-mouse 1:200, Invitrogen). Images were obtained using an upright
epifluorescent microscope (Nikon 80i, CoolSnapES camera). Labeled neurons were counted in
at least 3 randomly selected sections separated by >50μm per animal. The size distribution of
PKCδ+ neurons was determined using ImageJ software to measure cell diameter. The
percentage of PKCδ+ neurons that also expressed CGRP or IB4 was determined using dual
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labeling for PKCδ and CGRP (goat anti-CGRP 1:400, Serotec) or Alexa-568 conjugated to IB4
(1:400, Invitrogen) using the above-described procedures. PKCδ-TRPV1 coexpression was
determined using a goat anti-PKCδ antibody (1:50, Santa Cruz) and a rabbit antibody directed
against the TRPV1 C-terminus peptide (1:500) [24].

Calcium imaging
Scratching behavior was evoked with pruritic stimuli applied to the back skin where site
directed scratching occurs. We expanded our functional analyses of neuronal physiology to
include both thoracic and lumbar DRG. Mice were euthanized rapidly by decapitation and DRG
removed and acutely dissociated using previously described methods [25]. Briefly, DRG were
incubated in 45U papain/L-cysteine in Hank’s buffered saline solution (HBSS) without Ca2+ or
Mg2+ and with 10mM HEPES for 20 minutes at 37°C and 5% CO2. Ganglia were then washed,
followed by 20 minute incubation in 1.5 mg/ml collagenase in HBSS+HEPES. Ganglia were then
triturated with fire-polished Pasteur pipettes, the dissociated cells were filtered through a 40 μm
cell strainer, and were plated on poly-D-lysine and collagen-coated glass coverslips. Cells were
incubated overnight at 37°C in 5% CO2 humidified air in culture medium (Neurobasal A with B27,
pen/strep, 2mM glutamax, 5% fetal bovine serum (Gibco)). All experiments were performed within
24 hours of plating.
Cells were incubated in 3μg/ml Fura-2 AM (Molecular Probes) for 30 minutes and then
incubated for 30 minutes in external solution (in mM): 130 NaCl, 5 KCl, 2 CaCl2, 1 MgCl2, 30
Glucose, 10 HEPES. For each recording, a coverslip was placed in a perfusion chamber and
perfused with external solution at room temperature. Cells were viewed under an inverted
microscope (Olympus Optical, Tokyo, Japan) and images were captured with a Hamamatsu Orca
camera. SimplePCI Software was used to draw regions of interest (ROI) around Fura-loaded cells
prior to recording. The ratio of fluorescence emission at an excitation wavelength of 357 and
380nm was measured for each ROI. The experimental protocol consisted of a 2 minute baseline
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followed by 30 second bath application of histamine (100μM in external solution), >8 minutes of
external solution wash, 10 second application of capsaicin (200nM), >8 minutes of external
solution wash, and 10 seconds of KCl (50mM) followed by wash (<2 minutes) to determine live
neurons. A 10% or greater change from baseline 357nm/380nm ratio was considered a response
to histamine. Capsaicin experiments were performed similarly except with 10 second capsaicin
application (200nM). For experiments using PKCδ peptide inhibitor and scrambled peptide, cells
were incubated in 100μM peptide solution (dissolved in external solution) for 30 minutes prior to
recording (δV1-1 peptide inhibitor (Myr-SFNSYELGSL-NH2), peptide inhibitor scramble (MyrGLSFSEYLSN-NH2), Biomatik).

List of abbreviations
PKC: protein kinase C; GqPCR: Gq protein-coupled receptor; MRGPR: Mas-related gene protein
coupled receptor; CQ: chloroquine; KO: knock-out; WT: wild type; DRG: dorsal root ganglion; SC:
spinal cord; PLC: phospholipase C; PIP2: phosphatidylinositol; IP3: inositoltriphosphate; DAG:
diacylglycerol; H1R: histamine receptor 1; ERK1/2: extracellular signal regulated kinase 1/2;
CGRP: calcitonin gene-related peptide; IB4: isolectin B4; Scr: scramble; Inh: inhibitor; PBS:
phosphate-buffered saline; HBSS: Hank’s buffered saline solution; IHC: immunohistochemistry;
TRPV1: transient receptor potential vanilloid receptor 1; TRPA1: transient receptor potential
cation channel, subfamily A, member 1; PGE2: prostaglandin E2; NGF: nerve growth factor; IL-6:
interleukin-6
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Results
PKCδ mediates histamine-induced itch
To determine if PKCδ plays a role in behavioral responses to itch, we assessed scratching
responses to histamine and non-histaminergic pruritogens in PKCδ knock-out mice (PKCδ-KO)
and their wild type littermates. Mice were injected intradermally at the nape of the neck with one
of three pruritogens: histamine (1mg), chloroquine (CQ) (200μg), or β-alanine (223μg). PKCδ-KO
mice scratched significantly less than their wild type littermates when injected with histamine
(Figure 1A, p<0.05). On the other hand, chloroquine-induced scratching was not significantly
different between WT and PKCδ KO mice (Figure 1B, p=0.129). There was also no difference in
the number of scratch bouts induced by β-alanine (Figure 1C, p=0.61). These results indicate that
PKCδ mediates histaminergic itch, but is not necessary for non-histaminergic itch induced by CQ
and β-alanine.

Figure 1. PKCδ-KO and WT scratching responses to pruritogens. A. PKCδ-KO mice
scratched less than wild type littermates in response to intradermal histamine injection
(WT=121.4±12.8 scratch bouts/30min, n=25; KO=73.8±15.5 scratch bouts/30min, n=19;
unpaired t test p<0.05). B. Chloroquine (CQ)-induced scratching was not different between
PKCδ-KO and WT mice (WT=163.7±22.6 scratch bouts/30min, n=23; KO=118.0±18.9 scratch
bouts/30min, n=21; unpaired t test p=0.129). C. Scratch bouts induced by β-alanine were also
not different between PKCδ-KO and WT mice (WT=57.0±10 scratch bouts/30min, n=6;
KO=48.8±12.3 scratch bouts/30min, n=8; unpaired t test p=0.61).
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PKCδ is preferentially expressed in small diameter DRG neurons
PKCδ is expressed in a variety of tissues, including the brain and peripheral nervous
system [19, 21, 26-33]. To assess whether PKCδ is localized to potential pruriceptive sensory
neurons, immunohistochemistry (IHC) was used to characterize the distribution of PKCδ in dorsal
root ganglion (DRG) neurons. Antibody specificity was confirmed via western blot using PKCδKO DRG and spinal cord tissue. No antibody staining was found corresponding to the 78kD PKCδ
band in PKCδ-KO DRG tissue (Figure 2A). This was further confirmed by IHC of knock-out and
wild type DRG (Figure 2B). In wild type lumbar DRG, PKCδ was expressed in 43.2% of total
neurons labeled with βIII tubulin (567/1314 cells, n=3 animals) and PKCδ expression was

Figure 2. Immunological analyses of PKCδ in the spinal cord and DRG. A. Western blot
demonstrating expression of PKCδ in WT DRG and spinal cord (SC) but not in PKCδ-KO tissue
confirming the validity of the PKCδ antibody. B. Representative images of 18μm sections from
WT and PKCδ-KO lumbar DRG. (Scale bar = 50μm) C. Histogram of cell diameter
measurements of PKCδ+ and PKCδ- neurons illustrates the localization of PKCδ to small and
medium diameter soma.
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predominantly restricted to small diameter neurons (average diameter 23.3±0.19μm, min 11.6μm,
max 36.2μm) (Figure 2C).

Figure 3. Localization of PKCδ and markers of peptidergic and non-peptidergic dorsal
root ganglion neurons. A. Representative images of CGRP+, PKCδ+, and co-expressing
(Merge) DRG neurons. B. Graphical representation of total neurons counted and degree of
overlap (n = number of neurons). C, D. Representative images of IB4+, PKCδ+, and
IB4+/PKCδ+ neurons and illustration of overlap. E, F. Representative images of TRPV1+,
PKCδ+, and TRPV+/PKCδ+ neurons and illustration of overlap. Inset demonstrates TRPV1
antibody stain in TRPV1-KO mice. (Scale bar = 50μm; Arrowheads indicate example cells that
express both markers).
PKCδ is expressed in peptidergic and non-peptidergic DRG neurons
We further characterized PKCδ expression in small diameter DRG neurons by
immunohistochemical analysis of peptidergic and non-peptidergic markers. Of peptidergic
neurons identified by anti-Calcitonin Gene Related Peptide (CGRP+) immunoreactivity, 26.8%
expressed PKCδ, while 14.7% of PKCδ-expressing neurons were CGRP-positive (Table 1, Figure
3A-B). PKCδ was also expressed in non-peptidergic neurons identified by isolectin B4 (IB4)
binding. Of IB4+ DRG neurons, 61.6% expressed PKCδ and 55.0% of PKCδ+ neurons exhibited
IB4 binding (Table 1, Figure 3C-D). These findings indicate that PKCδ is expressed in both
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peptidergic and non-peptidergic sensory neurons, with greater expression overlap found with nonpeptidergic IB4+ neurons.
Behavioral and physiological studies have shown that itch produced by histamine is largely
dependent on the non-specific cation channel transient receptor potential vanilloid receptor 1
(TRPV1) [34-36]. Because PKC has previously been demonstrated to modulate TRPV1 function
and may present one potential mechanism by which PKCδ regulates itch, we determined the
degree of overlap between PKCδ and TRPV1 expression [24, 37]. We first confirmed the
specificity of our antibody directed against TRPV1 using TRPV1 knockout mice (Figure 3E, inset).
Our data indicate that 29.1% of PKCδ-positive neurons were also TRPV1-positive, and 48.9% of
TRPV1-positive neurons also expressed PKCδ, suggesting a potential functional relationship
between PKCδ and TRPV1 (Figure 3E-F; Table 1).
Table 1. Percent of DRG neurons in which PKCδ colocalizes with other markers (mean ±
SEM). (n = 3-4 mice per marker.)
% of PKCδ+ neurons
% of marker+ neurons
expressing marker
expressing PKCδ
Marker
CGRP
14.7 ± 2.5
26.8 ± 3.5
IB4

55.0 ± 3.0

61.6 ± 7.9

TRPV1

29.1 ± 2.2

48.9 ± 4.0

PKCδ-KO sensory neurons exhibit diminished responses to histamine
PKCδ is expressed in the brain, spinal cord, and the peripheral nervous system [33, 3841]. Therefore, global genetic deletion of PKCδ in our knockout mice makes it difficult to pinpoint
where PKCδ functions to modulate histamine-induced scratching. The expression of PKCδ in
small diameter sensory neurons suggests that it may mediate histamine-evoked itch by signaling
in nociceptive neurons responsive to pruritic agents (i.e., pruriceptors). To determine if PKCδ
directly modulates neuronal responses to histamine, calcium imaging was performed on acutely
dissociated adult mouse DRG neurons (Figure 4A-B). Of the total sensory neurons treated with
histamine, 11.1% of wild type neurons responded to bath application of 100μM histamine
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(126/1137 total WT neurons, N=5 animals), but only 6.7% of PKCδ-KO neurons responded to
histamine (47/706 total KO neurons, N=3 animals), indicating a significant reduction of 39.6% in
the proportion of histamine responsive neurons (p<0.01, χ2 test) (Figure 4C). No significant
difference in peak calcium responses to histamine was detected between knock-out and wild type
cells (WT 33.6±2.8% increase from baseline, n=126 cells; KO 39.9±6.6% increase from baseline,
n=47 cells, unpaired t-test, p=0.304) (Figure 4D).
We hypothesized that PKCδ could contribute to neuronal responses to histamine by
mediating histamine receptor coupling to TRPV1, or by regulating the normal expression or
function of TRPV1. To investigate whether the absence of PKCδ affects the activation of TRPV1
within histamine-responsive neurons, we applied the TRPV1-specific agonist capsaicin after the
histamine response. We found that 58.7% of WT histamine-responsive neurons subsequently
responded to capsaicin (74/126 total His+ neurons), while only 40.4% of KO histamine-sensitive
neurons responded to capsaicin (19/47 total His+ neurons; p<0.05, χ2 test) (Figure 4E). To
determine whether the functional expression of TRPV1 is altered in PKCδ-KO neurons, we tested
WT and KO sensory neurons for responses to capsaicin. There were no differences in the total
number of capsaicin-responsive neurons between KO and WT groups (117/194 (60.3%) WT
neurons, 144/259 (55.6%) KO neurons, p=0.315, χ2 test, Figure 4G). Together, these data
indicate that the reduction in histamine responses is not due to altered levels of TRPV1 receptors
in the KO, and support the idea that PKCδ could modulate TRPV1 downstream of histamine
receptor activation.
To further control for the possibility of developmental effects or compensatory
mechanisms that may occur with congenital genetic deletion of PKCδ, we performed calcium
imaging experiments with the same experimental design using acute pharmacological inhibition
in wild type DRG cultures. The δV1-1 peptide inhibitor has been shown to inhibit PKCδ activation
in vitro and in vivo by competitively binding to receptor for activated C-kinase (RACK)
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Figure 4. PKCδ mediates sensory neuron responses to histamine. A. Representative
image of dissociated DRG neurons loaded with Fura2-AM. B. Representative traces of
selected cells (corresponding colored circles in A) in response to histamine, capsaicin, and
KCl. C. Proportion of total histamine responders in WT and KO DRG neurons (WT=11.1%
(126/1137 total WT neurons); KO=6.7% (47/706 total KO neurons); ** p<0.01, χ2 test). D. Peak
calcium increase in response to histamine, defined as % signal increase above baseline. WT
33.6±2.8% change from baseline, n=126 cells; KO 39.9±6.6% change from baseline, n=47
cells, unpaired t-test, p=0.304. E. Percent of histamine-responsive neurons that responded to
capsaicin (74/126 WT His+ neurons; 19/47 KO His+ neurons; p<0.05, χ2 test). F. Proportion of
capsaicin-responsive neurons (117/194 WT neurons, 144/259 KO neurons, p=0.315, χ2 test).
G. Proportion of histamine-responsive neurons in scramble- vs. inhibitor-treated groups
(18.5% (75/405) of scramble-treated neurons vs. 13.1% (69/527) of peptide-treated neurons,
p<0.05, χ2 test). H. Peak calcium increase in response to histamine (inhibitor: 33.23±2.7%
change from baseline, n=69 cells; scramble: 41.0±3.7% change from baseline, n=75 cells,
p=0.095, unpaired t test).
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proteins, which confer PKC isoform substrate specificity [31, 42-45]. DRG neurons were
incubated with the peptide inhibitor δV1-1 for 30 minutes prior to recording. Consistent with our
findings in PKCδ-KO neurons, there was a significant reduction in the total number of histamineresponsive neurons treated with peptide inhibitor when compared to scramble peptide-treated
control neurons (18.5% (75/405) of scramble-treated neurons vs. 13.1% (69/527) of peptidetreated neurons, N=4 animals, p<0.05, χ2 test) (Figure 4F). Peak calcium responses induced by
histamine were not different between inhibitor- and scramble-treated groups (inhibitor 33.23±2.7%
change from baseline, n=69 cells; scramble 41.0±3.7% change from baseline, n=75 cells,
p=0.095, unpaired t test) (Figure 4G).
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Discussion
Pruritic stimuli can activate sensory neurons via specific intracellular signaling cascades,
which represent potential targets for anti-pruritics, but these cascades remain poorly understood.
Characterizing signaling components is a significant challenge, in part because of the great
diversity of recently identified pruritic receptors. Some receptors involved in pruritus are coupled
to Gi/o cascades such as the H4 histamine receptor, while others utilize kinase signaling pathways
like the TSLP/IL-7 receptors [6, 7, 46, 47]. However, the majority of identified pruritic receptors,
including the H1 receptor and the “orphan” family of MRGPR receptors, are linked by a common
Gαq signaling mechanism [10, 48-51]. In this study we focused on a component downstream of
the canonical Gαq signaling pathway, the serine/threonine kinase PKC.
PKC isozymes are divided into three groups: classic (activated by DAG and Ca2+), novel
(activated by DAG but not Ca2+), and atypical (activated by neither DAG nor Ca2+) [52, 53].
Specific PKC isoforms have been shown to selectively regulate nociceptive behavior and
nociceptor physiology [16, 17, 19, 54-60]. We previously showed that the novel isozyme PKCδ is
dispensable for acute mechanical and thermal nociceptive behaviors [20]. Previous reports have
implicated PKCδ in H1R signaling in non-neuronal cells [21, 22], but the specific role of PKCδ in
pruriceptor signaling and itch had not been explored. In this study we found that PKCδ was
necessary for the full expression of histamine-induced itch, but it did not have significant effects
on histamine-independent itch produced by the MRGPR ligands chloroquine or β-alanine.
To determine whether the scratching deficit we observed in PKCδ null mice could be
attributed to loss of function within sensory neurons, we examined anti-PKCδ staining in mouse
lumbar DRG. Previous studies indicated that PKCδ is expressed in murine spinal cord and DRG,
but the precise subset of PKCδ-positive neurons had not been characterized [33, 38-41]. We
found that PKCδ expression was restricted to small diameter dorsal root ganglion neurons.
Furthermore, although PKCδ was expressed in both peptidergic and non-peptidergic sensory
neurons, it was greatly enriched in the non-peptidergic subset. Both peptidergic and
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nonpeptidergic fibers have been shown to play a role in pruritus. Histaminergic itch is largely
dependent on CGRPα-positive neurons [61], however, a subset of histamine-responsive neurons
also express the nonpeptidergic marker IB4 [11, 62].
Calcium imaging studies of dissociated DRG neurons demonstrated that genetic deletion
of PKCδ resulted in a significant reduction of the proportion of adult sensory neurons that were
histamine-responsive. We further confirmed these results using acute pharmacological inhibition,
supporting the hypothesis that PKCδ functions within normal wild type sensory neurons to
mediate acute histaminergic signaling. The expression of PKCδ in small diameter sensory
neurons, along with the reduction of histamine-responsive sensory neurons, suggest a peripheral
mechanism for the behavioral effects of global PKCδ deletion on histamine-induced scratching.
Following histamine release, sensory neuron signaling to produce itch is thought to
depend on functional coupling of H1R to TRPV1. Supporting this idea, mice lacking TRPV1 exhibit
greatly reduced scratching behavior and cellular responses to histamine, and blocking TRPV1
channel function likewise abolishes the response of sensory neurons to histamine [34, 36, 63].
The mechanisms by which H1R recruits TRPV1 are complex and several different signaling
pathways have been implicated [35, 36, 64, 65]. One possible mechanism by which histamine
could couple to TRPV1 in sensory neurons is through PLC-induced PKC activation. This is further
supported by an expanding body of literature indicating that PKC directly modulates TRPV1
function [24, 37]. Indeed, inhibitors for PLC and PKC prevent histamine-induced TRPV1potentiation [64]. We previously found that acute mechanical and thermal pain were independent
of PKCδ. In contrast, PKCδ was necessary for the full expression of thermal hyperalgesia during
Complete Freund’s Adjuvant-induced inflammation, which is a TRPV1 dependent process [20].
In this study, 49% of TRPV1-expressing neurons were PKCδ-positive and we showed a
significant reduction in the proportion of capsaicin-responsive neurons within the subset of
neurons responsive to histamine. Additionally, sensory neurons from PKCδ-KO mice not
previously treated with histamine responded similarly to wild type neurons when challenged with
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capsaicin. These observations indicate that acute detection of heat stimuli by TRPV1 is not
dependent on PKCδ, but suggest that PKCδ could function downstream of the histamine receptor
to modulate TRPV1 function. In further support of this idea, several other inflammatory mediators
including PGE2, NGF, and IL-6 have been shown to activate PKCδ [41, 66-68]. It is possible that
pruritic dermatoses marked by inflammation may recruit PKCδ, resulting in sensory neuron
modulation that could potentiate itch.
In contrast to histaminergic signaling, the MRGPR receptors appear to produce their
pruritic effects through an alternative, PKCδ-independent pathway. Chloroquine activates
MRGRPA3 which couples to the irritant receptor TRPA1 to produce itch. Neuronal responses to
chloroquine were prevented by inhibiting Gβγ subunit activity, suggesting that the Gαq pathway is
not necessary for chloroquine-induced itch [15]. However, MRGPRA3 was also recently shown
to sensitize TRPV1 via a PKC mechanism likely dependent on Gαq signaling, suggesting a
possible mechanism for thermal sensitization [69]. This suggests that MRGPRA3 may have
biased signaling mechanisms that lead to itch and/or TRPV1-related sensitization. Thus, the
histamine receptor and MRGPRs may share a pathway leading to sensitization of TRPV1 via PKC
signaling, despite an alternative Gβγ mechanism for MRGPRA3 signaling of itch [48, 70].
In summary, we found that PKCδ is a mediator of histaminergic itch signaling in sensory
neurons. Although we specifically investigated PKCδ in this study, other PKC isoforms may also
be involved in modulating the response to itch. For example, another novel PKC isozyme, PKCε,
is expressed in largely IB4+ neurons, and has been shown to also modulate TRPV1 responses
[16, 59, 60, 71]. The sensory neuron responses involved in itch are complex, involving multiple
molecular cascades which may be differentially mediated by specific PKC isoforms. Future
studies that investigate the roles of PKC isozymes in itch may contribute to better therapeutic
specificity for the treatment of acute and chronic pruritus.
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Chapter 3

Enhanced non-peptidergic intraepidermal fiber density and an expanded
subset of chloroquine-responsive neurons in a mouse model of dry skin itch

This chapter contains the manuscript:
Valtcheva MV, Samineni VK, Golden JP, Gereau RW, Davidson S. Enhanced nonpeptidergic
intraepidermal fiber density and an expanded subset of chloroquine-responsive trigeminal
neurons in a mouse model of dry skin itch. The journal of pain: official journal of the American
Pain Society. 2015;16(4):346-56. doi: 10.1016/j.jpain.2015.01.005. PubMed PMID: 25640289;
PubMed Central PMCID: PMC4385451
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Abstract
Chronic pruritic conditions are often associated with dry skin and loss of epidermal barrier
integrity. In this study, repeated application of acetone and ether, followed by water (AEW) to the
cheek skin of mice produced persistent scratching behavior with no increase in pain-related
forelimb wiping, indicating the generation of itch without pain. Cheek skin immunohistochemistry
showed a 64.5% increase in total epidermal innervation in AEW-treated mice compared to watertreated controls. This increase was independent of scratching, because mice prevented from
scratching by Elizabethan collars showed similar hyperinnervation. To determine the effects of
dry skin treatment on specific subsets of peripheral fibers, we examined Ret-positive, CGRPpositive, and GFRα3-positive intraepidermal fiber density. AEW treatment increased Ret-positive
fibers, but not CGRP-positive or GFRα3-positive fibers, suggesting that a specific subset of nonpeptidergic fibers could contribute to dry skin itch. To test whether trigeminal ganglion neurons
innervating the cheek exhibited altered excitability after AEW treatment, primary cultures of
retrogradely labeled neurons were examined using whole-cell patch clamp electrophysiology.
AEW treatment produced no differences in measures of excitability compared to water-treated
controls. In contrast, a significantly higher proportion of trigeminal ganglion neurons were
responsive to the non-histaminergic pruritogen chloroquine after AEW treatment. We conclude
that non-peptidergic, Ret-positive fibers and chloroquine-sensitive neurons may contribute to dry
skin pruritus.
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Introduction
Pruritus is a primary complaint associated with xerosis (dry skin) and other dermatoses
that compromise skin barrier integrity such as atopic dermatitis and psoriasis [1, 2]. A rodent
model of persistent and ongoing dry skin pruritus was previously developed by application of
equal parts acetone and ether followed by water (AEW) to the rostral back skin [3]. Adaptation of
the AEW model to the hind-limb, where biting and licking behaviors were used to indicate itch,
showed an absence of behavioral sensitization to heat and mechanical stimuli, suggesting the
dry skin produced itch but not hyperalgesia [4]. Recently, clear differentiation between pain and
itch behaviors was achieved by application of algogens or pruritogens to the rodent cheek [5, 6].
When repeated AEW treatments were applied to the cheek, hind-limb scratching behavior was
evoked, indicating that dry skin produced ongoing itch [7].
The mechanisms by which dry skin generates itch are unclear. Intriguingly, human pruritic
dermatoses are frequently associated with increased intraepidermal fiber density [8-11].
Increased intraepidermal fiber density was also reported after a single, acute application of
acetone in rodents [12, 13], and has been hypothesized to occur in AEW-induced itch [14].
However, scratching after AEW treatment develops with a latency of 3 days, suggesting that the
sprouting fibers observed after a single treatment may be insufficient to induce itch [3, 4, 15]. The
identity of the expanded peripheral fibers is not known, nor is it understood whether fiber
hyperinnervation directly contributes to pruritus.
In addition to possible changes in epidermal innervation, enhancement of pruritic receptor
function and phenotypic switching of sensory neurons into pruriceptors may contribute to the
increased itch generated by dry skin. Like many intractable pruritic conditions, AEW-induced itch
is thought to be histamine-independent [3]. Novel non-histaminergic neural pathways and pruritic
receptors have recently been identified [16]. Importantly, members of the Mas-related gene
protein receptor family (Mrgprs) are activated by the non-histaminergic pruritogen chloroquine,
and ablation of MrgprA3 resulted in decreased scratching after AEW treatment [17, 18]. MrgprA3
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is functionally coupled to TRPA1, a channel that exhibits sensitivity to a wide range of irritants
including mustard oil and formalin [19-22]. A significant reduction in scratching was observed in
TRPA1 knock-out mice exposed to AEW treatment. Furthermore, AEW treatment induced
upregulation of MrgprA3 mRNA, suggesting that these receptors may contribute to dry skininduced itch [7].
The aim of this study was to determine the effects of dry skin pruritus on peripheral fiber
anatomy and the physiological properties of sensory neurons innervating dry skin. Intraepidermal
innervation was characterized and quantified with and without scratch-preventing Elizabethan
collars to determine whether scratching itself contributes to changes in nerve fiber density in dry
skin. We tested the hypothesis that dry skin produces peripheral sensitization by enhancing the
excitability of trigeminal neurons. Finally, we monitored calcium responses evoked by chloroquine
and mustard oil from AEW-treated and control animals to test for altered expression or function
of itch-related receptors.
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Materials and Methods
Animals and Acetone-Ether-Water (AEW) treatment
All experiments were conducted in accordance with the National Institutes of Health
guidelines and received the approval of the Animal Care and Use Committee of Washington
University, School of Medicine. 8-12 week old littermate mice (C57BL/6 (Jackson lab) or RetEGFP [23, 24]) were housed on a 12 hour light-dark cycle and allowed ad libitum access to food
and water. Ret-EGFP reporter mice (129/SvJ:C57BL/6) were obtained from Dr. Jain [23]. Cheek
skin was shaved with electric clippers one day prior to the start of acetone-ether-water treatments.
The acetone-ether group was treated with a 1:1 mixture of acetone and diethyl ether (Sigma, St.
Louis, MO) for 30 seconds by soaking and then applying a gauze-wrapped cotton tip to the cheek,
followed by similarly applied water for 30 seconds. Control animals were treated with water only.
After 6 days of twice per day treatments (morning and evening), scratching behavior was
quantified 6-8 hours after the final AEW treatment. Mice were placed in individual observation
chambers and allowed to acclimate for 1 hour prior to observation. Bouts of scratching were then
counted for 1 hour with experimenters blinded to treatment. A bout of scratching was defined as
any number of individual scratch events separated by a pause. During the pause, behaviors such
as licking or biting of the hind-limb, holding the limb motionless, or putting the limb down on the
surface, could occur. Wiping behavior was taken to indicate pain and was defined as a rostrallydirected movement of the ipsilateral forelimb across the cheek starting from the ear [5, 6].
Scratching behavior with continued AEW treatment has been reported to persist for at least 2
weeks [4, 15].

Immunohistochemistry
After six days of AEW treatment, mice were deeply anesthetized (ketamine-xylazineacepromazine: 38-1.92-0.38 mg/mL; 2.7 mL/kg). The treated skin was dissected and immersionfixed in Zamboni’s fixative for 4 hours, rinsed in PBS, and cryoprotected in 30% sucrose, then
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sectioned at 30𝜇m and collected on slides. Wild type C57BL/6 mice were used to determine β-III
tubulin, CGRP, and GFRα3 fiber innervation, while a separate strain of Ret-EGFP reporter
mice[23, 24] were used to determine Ret-positive fiber density. Antibodies and dilutions: rabbit
anti-βIII tubulin (1:1000, Covance), goat anti-CGRP (1:1000, Serotec), goat anti-GFRα3 (1:100,
R&D Systems), rabbit anti-GFP (1:1000, Invitrogen), Alexa Fluor 488/555 donkey anti-rabbit
(1:200-400, Invitrogen), Alexa Fluor 488 donkey anti-goat (1:200-350, Invitrogen). These
concentrations are based on previous demonstrations of intraepidermal fiber staining [24-26].
Specificity of the GFRα3 antibody was previously shown using a GFRα3 knock-out mouse [27].
All slides were stained with bisbenzamide (1:40,000, Sigma, St. Louis, MO.) and MetaMorph
Software (Molecular Devices, Sunnyvale, CA.) was used to measure the length of the dermalepidermal border. In each examined section labeled fibers crossing the dermal-epidermal border
were counted on an upright epifluorescent microscope (Nikon 80i; CoolSnapES camera). Six
examined sections separated by >60µm were analyzed for each animal and the mean fiber
density was calculated. To determine whether changes in fiber innervation were dependent on
scratching, modified Elizabethan collars (Harvard Apparatus, Holliston, MA.) were secured at the
start of treatment in both AEW and water-only groups. For hematoxylin and eosin (H&E) staining,
tissue was fixed in Zamboni’s fixative for 2-4 hours, then embedded in paraffin. Sections 10 µm
thick were stained using standard H&E methods [28]. Representative images of fibers stained
with the above-described methods were obtained using a Leica SPE Confocal microscope.
Images were collected across the z-plane at 1µm width and maximum projection images were
generated using ImageJ software.

Culture of trigeminal ganglion neurons
Wild type mice were sacrificed by decapitation after nine days of treatment and the
ipsilateral trigeminal ganglia (TG) were removed and cut into several pieces. Ganglia were
incubated in 45U papain (Worthington, Lakewood, NJ) in 3 mL Hank’s buffered saline solution
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without Ca2+ or Mg2+ and with 10 mM HEPES at 37°C, 5% CO2 for 20 minutes. TG were washed
and then incubated in collagenase (1.5 mg/ml) for 20 minutes. TG were triturated with a firepolished Pasteur pipette, then passed through a 40μm filter, and the dissociated cells were plated
on poly-D-lysine and collagen coated glass coverslips. Cells were cultured overnight in
Neurobasal A media supplemented with B27, 100U/mL penicillin/streptomycin, 2 mM Glutamax,
and 5% fetal bovine serum (Gibco). No additional growth factors were added to the media. All
experiments were performed within 24 hours of plating.

Whole-cell patch clamp electrophysiology
For electrophysiology experiments, FastDiI (Sigma, St. Louis, MO.) was injected
intradermally into the cheek of wild type mice on day 2 of AEW or water treatment to label
trigeminal neurons innervating the skin at the treatment site. After seven additional days of AEW
or water treatment to allow maximum retrograde labeling of trigeminal neurons, including
sprouting terminals, trigeminal ganglia were cultured as described above. Retrogradely labeled
trigeminal neurons from AEW- or water-treated mice were then identified using an Olympus BX50 epifluorescence microscope and subsequently examined for differences in membrane
excitability. Cells were tested in an external recording solution consisting of (in mM): 145 NaCl, 3
KCl, 2.5 CaCl2, 1.2 MgCl2, 7 Glucose, and 10 HEPES, adjusted to pH 7.4 with NaOH and 305
mOsm with sucrose. Borosilicate, filamented glass electrodes with 2-5 MΩ resistance (Warner
Instruments, Hamden, CT) contained internal solution (in mM): 130 K-gluconate, 5 KCl, 5 NaCl,
3 Mg-ATP, 0.3 EGTA, 10 HEPES, adjusted to pH 7.3 with KOH and 294 mOsm with sucrose.
After acquiring gigaseal and break-in, neurons were given 2 minutes to stabilize and then a series
of protocols to determine membrane excitability were performed. Action potentials were evoked
in current clamp mode using a series of increasing 1 second ramp current injections. The first
action potential of a train was used to determine threshold, defined as the voltage at which the
first derivative of the membrane potential increased by 10 V/s. Rheobase was established from
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the step current pulse at which the first action potential was triggered. Data were collected with a
HEKA EPC 10 amplifier, digitized at 20 kHz, and recorded on a PC running Patchmaster software
(v2x-71). Series resistance was kept below 10 MΩ in all recordings and only DiI labeled cells with
a diameter less than 30 µm were studied.

Calcium imaging
The protocol for calcium imaging was adapted from our previous studies [29-32]. Cells
from wild type mice were incubated for 45 minutes in 3 μg/mL of the cell-permeant ratiometric
calcium indicator Fura-2 AM (Molecular Probes) and then incubated in external solution (in mM):
130 NaCl, 5 K, 2 CaCl2, 1 MgCl2, 30 Glucose, 10 HEPES for a 30 minute de-esterification prior to
recording. Coverslips were positioned in a recording chamber and perfused with external solution
at room temperature. Cells were viewed under an inverted microscope (Olympus Optical, Tokyo,
Japan) and images were captured with a Hamamatsu Orca camera. Regions of interest
encompassing all Fura-loaded cells were identified a priori and the ratio of fluorescence emission
at an alternating excitation wavelength of 357 and 380 nm was recorded with SimplePCI Software.
The experimental protocol consisted of a 2 minute baseline followed by 30 second bath
application of 100 μM mustard oil (MO, Sigma, St. Louis), 8 minutes of external solution, 30
seconds of 1mM chloroquine (CQ, Sigma, St. Louis), 8 minutes of external solution, and 10
seconds of high KCl (50mM). Peak responses were determined by calculating the absolute
increase in Fura-2 signal above baseline immediately prior to each stimulus. A change from
resting level of ≥20% was set as the threshold for a response to a bath applied chemical. Cells
unresponsive to high K+ were excluded from physiological analysis.

Statistical analyses
All statistical analyses were performed using GraphPad Prism 6.04 (2014). For
comparisons between AEW-treated and water-treated scratching behavior, unpaired t-test was
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used to compare the total scratch bouts or wipes per 60-minute interval. Electrophysiological data
comparisons were performed using unpaired t-test. Differences between the proportion of
responders in AEW and water groups were determined using a χ2 test. Peak calcium increase in
response to stimuli was analyzed with unpaired t-test. For all statistical analyses, significance was
defined as p<0.05. Data are presented as mean ± S.E.M.

58

Results
AEW-induced dry skin elicits scratching but not wiping behavior
AEW treatment induced grossly visible, dry and scaly skin on the treated cheek of mice,
whereas skin from water treated mice appeared unchanged (Figure 1A, B). AEW treatment also
induced a hyperproliferation of keratinocytes resulting in thickening of the epidermis that was not
observed in the water-only controls. The dry skin group was marked by spongiosis and large
pieces of dissociating stratum corneum which still contained nucleated keratinocytes (Figure 1C,
D). AEW treatment induced a significant increase in the number of site-directed bouts of
scratching (H2O = 4.0 ± 2.3 scratch bouts, AEW = 60.7 ± 17.0 scratch bouts, unpaired t-test,
p≤0.01; Figure 1E). In contrast, very little wiping behavior was observed in general and no
difference in the number of wipes was observed between water-only and AEW treatment groups
(H2O = 1.0 ± 0.8 wipes, AEW = 4.4 ± 1.7 wipes; unpaired t-test, Figure 1F). These results indicate
that AEW-induced dry skin elicits ongoing itch without pain.

Figure 1. Dry skin treatment induces itch without pain. A, B) Photographs of shaved mouse
cheeks after treatment with water or acetone/ether and water. AEW treatment induced scaly, dry
skin. C, D) H&E staining shows epidermal hyperplasia and hyperkeratosis in the AEW treated
group but not in the water treated group. Stratum corneum still containing nucleated keratinocytes
can be seen in the process of dissociating from the epidermis. Scale bar = 50µm. E, F)
Quantification of the mean number of scratch bouts and wipes during 1 hour of observation after
6 days of AEW treatment. AEW treatment greatly enhanced scratching (p< 0.01, unpaired t-test,
water-treated n=9; AEW-treated n=11) but little wiping occurred and was not significantly different
between water and AEW groups (n=5 each group, unpaired t-test).
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Dry skin induces intraepidermal hyperinnervation independent of scratching
To determine whether dry skin alters intraepidermal nerve fiber density (IENFD), we
quantified fiber innervation in the cheek epidermis from AEW- and water-treated mice. IENFD
was measured using an antibody against β-III tubulin, which is specific for neurons and labels
axons and their terminals (Figure 2).[33] IENFD was significantly increased in the AEW-treated
group compared to water-only controls (H2O = 26.8 ± 4.2 fibers/mm, AEW=44.1 ± 5.4 fibers/mm,
n=5 animals per group, unpaired t-test, p<0.05) (Figure 2A - C).

Figure 2. Dry skin induces intraepidermal hyperinnervation independent of scratching. A,
B) Mice treated with acetone/ether and then water showed increased fiber innervation and
epidermal hyperplasia compared to the water treated animals. Scale bar = 20µm. C)
Intraepidermal fiber innervation was significantly increased by AEW treatment. D, E) Mice with
Elizabethan collars placed at the start of treatment also showed increased fiber density and
thickening of the epidermis. Scale bar = 20µm. F) No change in the magnitude of AEW-induced
hyperinnervation relative to water-only controls was observed between collared and non-collared
mice after AEW treatment.
Scratching itself is thought to promote itch via a positive-feedback loop known as the “itchscratch cycle”, and could alter fiber innervation. We sought to determine whether AEW-induced
dry skin is itself capable of generating epidermal hyperinnervation, or whether scratching behavior
was necessary to observe the increased IENFD. To this end, mice were fitted with Elizabethan
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collars to prevent scratching of the cheek for the duration of the AEW and water treatments. AEWtreated mice that wore collars also showed an increase in IENFD (H2O = 45.5 ± 1.8 fibers/mm,
AEW = 70.2 ± 1.7 fibers/mm, n=3 animals per group, unpaired t-test, p<0.001) (Figure 2D, E).
The magnitude of hyperinnervation relative to water controls (Fold Change) was not different
between the no collar and collar groups (no collar = 1.5 ± 0.2 fold increase relative to water, n=5
animals; collar = 1.5 ± 0.04 fold increase relative to water, n=3 animals, unpaired t-test, p=0.89)
(Figure 2F), indicating that AEW treatment induced epidermal hyperinnervation independent of
scratching.

Dry skin selectively induces hyperinnervation by Ret-positive, non-peptidergic fibers
Both peptidergic and non-peptidergic fibers are present in the epidermis and may
contribute to pruritus. However, βIII-tubulin is an indiscriminant marker of nerve fibers. Therefore,
to determine the subsets of sensory fibers that are increased in AEW-induced dry skin, peptidergic
fiber density was assessed with an anti-CGRP antibody. There were no significant changes in
CGRP-positive IENFD in the dry skin group when compared to water controls (H2O = 10.2 ± 1.4
fibers/mm, AEW = 8.9 ± 2.1 fibers/mm, n = 5 animals per group, unpaired t-test, p=0.62) (Figure
3A - C). Ret-EGFP reporter mice were used to identify Ret-positive (non-peptidergic) fibers, which
were visualized using an anti-GFP antibody.[24] The density of Ret-positive epidermal fibers was
significantly increased in the dry skin group (H2O = 40.2 ± 1.1 fibers/mm, AEW = 70.1 ± 7.6
fibers/mm, n = 4 animals per group, unpaired t-test, p<0.01) (Figure 3D – F). A small subset of
fibers that express both peptidergic and non-peptidergic markers can be identified by their
expression of the artemin co-receptor GFRα3.[34] Intraepidermal fiber density of these fibers was
quantified using an antibody directed against the GFRα3 receptor and no change in innervation
after AEW treatment was observed (H2O = 16.0 ± 1.2 fibers/mm, AEW = 14.9 ± 2.0 fibers/mm, n
= 4-5 animals per group, unpaired t-test, p=0.68) (Figure 3G-I). These data suggest that dry skin

61

induces branching and extension of non-peptidergic, Ret-positive epidermal fibers, which may be
important for the development or maintenance of dry skin-induced itch.

Figure 3. Hyperinnervation of Ret+, but not CGRP+ or GFRα3+ fibers after AEW treatment.
A, B) Intraepidermal CGRP+ fibers appeared no different in the AEW and water groups. Scale
bar = 20µm. Arrowheads indicate large pieces of dissociating stratum corneum which still
contained nucleated keratinocytes. C) Quantification of CGRP+ density. D, E) Photomicrographs
from a strain of mice in which eGFP is expressed from the Ret locus. eGFP immunostained fibers
in the cheek epidermis show increased fiber density after AEW-treatment. Scale bar = 20µm. F)
Quantification of Ret+ fiber density. G, H) IENFD of GFRα3+ fibers was not different between
AEW and water groups. I) Quantification of GFRα3+ density.
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We determined the proportion of trigeminal
neurons projecting to the skin that were also Retpositive by intradermal cheek injection of the
retrograde tracer DiI into untreated Ret-EGFP
mice. Trigeminal ganglia were harvested and
cultured and we found that the majority of
retrogradely labeled neurons were also Retpositive (Figure 4A, B). Of all retrogradely labeled
neurons, we found that 70.4 ± 4.1% were Retpositive (Figure 4C). Additionally, when tested for
physiological responses to KCl, we found that 92.4
Figure 4. Retrograde labeling of
trigeminal afferent fibers innervating
the cheek. A, B) Two injections of DiI
(10 uL each) into the cheek of an
untreated
Ret-EGFP
mouse
retrogradely labeled trigeminal ganglion
neurons that were later cultured. Arrows
show double-labeled neurons. C) 70.4 ±
4.1% of all DiI+ neurons were also Ret +
(n=10 coverslips, each circle represents
% per coverslip); 92.4 ± 2.7% KClresponsive, DiI+ neurons were also
Ret+ (n=5 coverslips). Total of 3 ReteGFP mice used.

± 2.7% of the KCl-responsive, DiI-positive cells
were also Ret-positive (Figure 4C). This increased
proportion of viable Ret-positive skin-projecting
neurons suggests a small loss of Ret-negative
neurons in culture.

Effects of dry skin on trigeminal neuron
physiology

We hypothesized that AEW treatment could alter the membrane excitability of trigeminal
neurons innervating the dry skin. We specifically targeted neurons with known peripheral
projections by retrogradely labeling trigeminal neurons with DiI injected into the cheek skin of
C57BL/6 AEW- and water-treated mice (Figure 5A). Whole-cell patch clamp electrophysiology
was then used to assess changes in membrane excitability. Rheobase was assessed using a
short step and action potential threshold was determined with the first spike evoked from a ramp
current (Figure 5B, C). Resting membrane potential of trigeminal neurons was not significantly
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different between AEW- and water-treated mice (H2O = -60.8 ± 2.7 mV, n=14 neurons, AEW = 57.2 ± 2.5 mV, n=15 neurons, unpaired t-test) (Figure 5D), and neither group showed
spontaneous activity. There was also no significant difference in the current amplitude required
to elicit an action potential between AEW- and water-treated animals (H2O = 614.3 ± 70.4 pA,
n=15; AEW = 453.3 ± 50.0 pA, n=15, unpaired t-test) (Figure 5E). Action potentials evoked by a
ramp current injection showed no difference between AEW and water treatment groups in the
threshold for activation (H2O = -8.7 ± 3.7 mV, n=10; AEW = -3.8 ± 1.9 mV, n=12, unpaired t-test)
(Figure 5F). Together, these data show that dry skin treatment did not produce ongoing activity
or changes in membrane excitability that could be determined in vitro.

Figure 5. Electrophysiology of AEW- and water-treated trigeminal neurons. A)
Photomicrograph of a patched wild type trigeminal neuron retrogradely labeled from the cheek
with DiI. (Scale bar = 30μm) B) Example trace of a short step protocol and evoked action potential
to determine rheobase. C) Example traces of the ramp current and evoked action potentials from
AEW- and water-treated trigeminal neurons. D) Resting membrane potential, E) Rheobase, and
F) Action potential threshold were not different between AEW- and water-treated groups.
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We next determined whether AEW-induced dry skin altered the responses of pruritic
receptors and pruriceptive neurons. Trigeminal ganglion neurons from AEW- and water-treated
wild type C57BL/6 mice were harvested, cultured, and loaded with Fura2-AM (Figure 6A). Wilson
et al., (2013) showed that TRPA1 is crucial for dry skin-induced itch and that MrgprA3 mRNA is
upregulated in sensory neurons after AEW treatment. To determine whether corresponding
functional changes occur in trigeminal neurons, intracellular calcium was monitored to test the
responses to the TRPA1 agonist mustard oil (MO) and non-histaminergic pruritogen chloroquine
(Figure 6B). We observed no significant difference between AEW- and water-treated groups in
the proportion of MO-responsive neurons (H2O = 89/1042 cells (8.54%), AEW = 107/1199 cells

Figure 6. Increased calcium responses to chloroquine in AEW-treated trigeminal
neurons in vitro. A) Image of Fura-2AM loaded trigeminal neurons with responses shown in
B. (Scale bar = 50μm) B) Example traces of mustard oil (MO, 100 μM) and chloroquine (CQ,
1 mM) responders, and a chloroquine responder without mustard oil sensitivity. C)
Quantification of the proportion of neurons responsive and magnitude of the response to
mustard oil from AEW- and water-treated animals. D) AEW increased the proportion of neurons
responsive to chloroquine but did not alter the magnitude of the response.
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(8.92%), χ2 test, p=0.81), or in the peak amplitude of the MO response (H2O = 101.4 ± 7% above
baseline, AEW = 112.7 ± 6% above baseline, unpaired t-test, p=0.24) (Figure 6C). On the other
hand, the proportion of CQ-responsive neurons in AEW-treated animals was significantly
increased by 27.2% (H2O = 127/1042 cells (12.19%), AEW = 186/1199 cells (15.51%), χ2 test,
p<0.05) (Figure 6D). Peak calcium responses to CQ were not different between the two groups
(H2O = 73.4±4% above baseline, AEW = 68.7±3% above baseline, unpaired t-test, p=0.34).
Most MO-responsive neurons also responded to CQ regardless of treatment (H2O = 77/89
(86.5%), AEW = 93/107 (86.9%), χ2 test, p=1). Of the CQ-responsive neurons, most responded
to MO in the water-treated group (77/127, 60.6%), while in the AEW group, half of CQ-responsive
neurons responded to MO (93/186, 50.0%). Therefore, a large proportion of CQ-responsive
neurons did not respond to MO. We tested whether the proportion of CQ-responsive neurons that
did not respond to MO was increased in the AEW group, but this did not reach significance (χ2
test, p=0.066).
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Discussion
Dry skin pruritus is a common problem and is often associated with other dermatoses.
Here we show that persistent dry skin induced both pruritus and epidermal hyperinnervation in
mice. We found that Ret-positive fibers contributed to the increased fiber density, but peptidergic,
CGRP-positive and GFRα3-positive fibers did not. Moreover, preventing scratching of the affected
area did not prevent dry skin-induced hyperinnervation. To understand whether sensitization or
ongoing activity of sensory neurons contributes to persistent dry skin pruritus, we performed in
vitro recordings from trigeminal neurons that were determined to have innervated the treated skin.
No evidence was found supporting the hypothesis that altered membrane excitability was
responsible for persistent dry skin itch. On the other hand, AEW treatment produced an increase
in the proportion of trigeminal neurons responsive to the histamine-independent pruritogen
chloroquine, supporting the concept that the Mrgpr family of receptors is upregulated and
functionally contributes to persistent dry skin itch.
In this study, AEW treatment of the cheek skin evoked scratching, but not forelimb wiping,
indicating the treatment produced ongoing itch without pain. A common feature in the affected
skin of patients with pruritic disease is increased epidermal innervation [9-11, 35]. Likewise,
increased fiber growth in the murine epidermis after AEW treatment has been noted [12, 13].
Here, persistent AEW treatment increased total epidermal fiber density by 65%, as indicated by
the pan-neuronal marker βIII-tubulin. We tested the possibility that mechanical stimulation from
scratching contributed to the fiber growth. When Elizabethan collars were fitted to prevent
scratching, intraepidermal innervation was still greater than in water-treated skin. The relative
increase did not differ from the hyperinnervation observed in the AEW-treated animals without
collars. These results demonstrate that dry skin itself is sufficient to induce hyperinnervation
without the presence of scratching.
In addition to hyperinnervation, histological studies of patients with atopic dermatitis or
psoriasis indicate that itch severity correlates positively with nerve growth factor (NGF) in the skin
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and the NGF-receptor TrkA in nerve fibers [9, 35-38]. Increased epidermal fibers and expression
of NGF have been observed in a mouse model of atopic dermatitis [39, 40], and in mice with acute
acetone-induced skin barrier dysfunction [12, 13]. While the specific contribution of
hyperinnervation to itch sensation is not clear, these observations suggest the idea that
peptidergic, TrkA-positive fibers may be important regulators of atopic and dry skin pruritus. The
present study shows that repeated AEW treatment resulted in persistent dry skin itch, but we
observed no increase of the CGRP-positive or GFRα3-positive fibers which likely express TrkA
[34]. This may be due to differences between the biology underlying human atopic dermatitis and
mouse models of acute dry skin. Our data do not rule out the possibility of functional contributions
to dry skin itch from the CGRP-positive or GFRα3-positive subset of fibers or other peptidergic
fibers, and it should be noted that fiber sprouting is not a prerequisite for sensory neurons to signal
itch.
A majority of the fibers innervating the epidermis are non-peptidergic and express the
receptor tyrosine kinase for the GDNF family of neurotrophic factor ligands, Ret, rather than TrkA
[24, 41]. GDNF release from skin keratinocytes and fibroblasts was recently acknowledged to
play an important role in sensory neurite outgrowth in vitro with implications for pruritus [42].
Artemin, which activates Ret and GFRα3, is increased in human atopic skin and artemin-treated
mice displayed increased sprouting of peripheral nerve fibers and itch-like behaviors [43].
Likewise, an increase in GFRα3 immunostained fibers was found in artemin over-expressing mice
[25, 26]. However, in the AEW model of dry skin no sprouting of GFRα3-positive fibers was
observed. Neurturin is another potentially interesting GDNF family ligand but its role in pruritus is
currently unknown. The Mrgpr family of histamine-independent receptors has been shown to be
selectively localized to Ret-positive DRG neurons and is expressed in epidermal nerve terminals
[17, 18, 41, 44, 45]. Our results show that AEW treated skin resulted in a significant increase in
Ret-positive fibers penetrating into the epidermis. This suggests that Ret-positive, non-peptidergic
fibers could play a role in itch induced by dry skin.
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The functional mechanisms engaged by pruriceptive sensory neurons to produce itch in
dry skin conditions remain unresolved, but are thought to be independent of histamine signaling.
Anti-histamines are generally not effective for treating chronic itch, including itch from dry skin [2,
46]. Furthermore, mast cell-deficient mice exhibit normal scratching after AEW treatment,
indicating that factors released from mast cells are unlikely to generate the itch from dry skin [3].
Recent studies have pointed to the involvement of specific non-histaminergic mechanisms for dry
skin itch. For example, ablation of the chloroquine-activated MrgprA3-expressing subset of
sensory neurons drastically reduced AEW-induced scratching [17]. Also, in vivo recordings from
spinal dorsal horn neurons showed enhanced responses to non-histaminergic pruritogens after
AEW treatment, but not to histamine [47]. Taken together, these studies support the idea that dry
skin pruritus signals through a non-histaminergic pathway.
Several signaling pathways for histamine-independent itch have now been identified.
Scratching in mice deficient for TRPA1 was greatly reduced after chloroquine or AEW treatment,
suggesting an important role for TRPA1 in non-histaminergic itch [7, 19]. Moreover, AEW
treatment increased the message for MrgprA3 in both skin and sensory neurons [7]. MrgprA3,
which functionally couples to TRPA1, is present on Ret-positive neurons, suggesting that dry skin
itch involves non-peptidergic fibers [17]. Although TRPA1 was initially shown to be expressed in
peptidergic sensory neurons [48], recent data have demonstrated robust modulation of TRPA1
function in Ret-positive neurons and TRPA1 expression in non-peptidergic IB4-positive fibers that
innervate the epidermis [25, 26, 49-52]. While the hyperinnervation of Ret-positive neurons is
consistent with a potential role in dry skin itch, functional studies are necessary to determine
whether changes in neural sensitization or receptor expression occur after AEW treatment.
To gain insight into the functional changes of potential pruriceptive neurons exposed to
dry skin, we hypothesized that locally released inflammatory mediators or neurotrophic factors
act directly on pruriceptive sensory neurons to induce sensitization. Peripheral sensitization could
explain the hyperknesis (heightened itch) and alloknesis (itch produced by a non-itchy stimulus)
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commonly associated with pruritic diseases. To target neurons that directly innervated the treated
skin, we performed whole-cell recordings from trigeminal ganglion neurons retrogradely labeled
from the cheek skin of animals exposed to AEW or water treatment. With this strategy, we found
no evidence for sensitization of trigeminal neurons in the AEW versus water-treated groups. It is
possible that culture conditions reset differences that may have existed in vivo and future studies
to examine the excitability of sensory fibers may yield different results. It is also possible that dry
skin is associated with changes in excitability that are more pronounced at the fiber terminals in
the skin and these did not translate into our in vitro studies of sensory neuron cell bodies. On the
other hand, previous studies have shown that manipulations in vivo have produced altered
sensory neuron physiology in vitro [53-55].
To test whether changes occur in the expression of functional pruritic receptors, we
examined receptor-mediated responses to mustard oil and chloroquine in cultured trigeminal
neurons from AEW- and water-treated animals. Interestingly, we found that AEW treatment
expanded the population of sensory neurons with functional responses to chloroquine. In contrast,
we found that responses to mustard oil were no different between AEW- and water-treated
animals. These results mirror data showing an increase in mRNA for MrgprA3, but not TRPA1, in
AEW-treated animals [7]. Overall, we found that ~10 percent of trigeminal neurons responded to
mustard oil, which is consistent with the expression of TRPA1 in sensory ganglion in several
reports [56-58]. While other studies have shown as many as 25% of sensory neurons are TRPA1positive, TRPA1 expression can vary by innervation target, exposure to growth factors, and
changes in other experimental methods [21, 48, 51]. Interestingly, many of the neurons that
responded to chloroquine after AEW showed no mustard oil responses at all, suggesting that the
MrgprA3 receptor may couple to other channels in addition to TRPA1. In favor of this idea,
MrgprA3 was recently found to modulate TRPM8, TRPC, and TRPV1 [59]. Additionally, TRPV3deficient mice exhibited greatly reduced scratching after AEW treatment compared to water-
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treated controls, indicating that other mechanisms in addition to TRPA1 may account for AEWinduced scratching [14].
In summary, our results show that dry skin-induced pruritus is associated with nonpeptidergic fiber growth into the epidermis and an expanded population of sensory neurons
responsive to the non-histaminergic pruritogen chloroquine. Although sprouting of peptidergic,
TrkA-positive fibers is observed in the skin of patients with atopic dermatitis and other
dermatoses, our results suggest that non-peptidergic fibers may also play a role in chronic itch
related to xerosis and compromised barrier integrity. Dry skin-induced itch, which particularly
affects the older population and often co-exists with other dermatoses, may be improved by
topical treatment directed at prevention of Ret-positive neural sprouting in the epidermis.
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Chapter 4
Neurotrophic factors selectively modulate pruritogen-evoked itch

This chapter is adapted from the following manuscript:
Valtcheva MV, Golden JP, Sheahan TD, Pullen MY, Vogt SK, Jain S, Davidson S, Gereau RW.
Neurotrophic factors selectively modulate pruritogen responses in mouse but not human sensory
neurons. 2016. In Preparation.
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Abstract
Neurotrophic factors such as nerve growth factor (NGF) and the glial cell line-derived
neurotrophic factor (GDNF) family of ligands (GFLs) regulate innervation and directly sensitize
nociceptors, but little is known about their role in itch. Studies of skin samples from patients with
chronic itch conditions such as atopic dermatitis and psoriasis demonstrate increased
intraepidermal nerve fiber density, increased artemin, and increased NGF and its receptor TrkA.
We tested the hypothesis that neurotrophic factors (NTFs) can modulate pruritogen-induced itch.
We investigated whether NGF and the GFLs GDNF, neurturin, and artemin can directly induce or
modulate histaminergic and non-histaminergic itch. Intradermal injection of NTFs into the cheek
skin of mice did not induce spontaneous scratching or wiping behavior, indicating that NTFs alone
do not induce pain or itch. Acute pretreatment with NGF selectively potentiated histamine-induced
scratching. On the other hand, artemin enhanced chloroquine-evoked itch, but reduced histamineinduced scratching. We studied dissociated trigeminal ganglion neurons from Ret-eGFP reporter
mice to examine the effects of NGF and artemin on calcium responses to pruritogens and
transient receptor potential (TRP) channel agonists. The vast majority of histamine- and
chloroquine-responsive neurons were Ret-positive. Overnight incubation with NGF significantly
increased the number of histamine responders. Both acute and overnight treatment with artemin
increased the proportion of chloroquine-responsive neurons. We also found that TrkAF592A
mutation resulted in altered TrkA signaling that produced an analgesic phenotype, but had no
effect on histamine- or chloroquine-induced itch. Our findings indicate that NGF and artemin have
select roles in the regulation of pruritogen-evoked itch. Additionally, TrkA signaling may not play
a prominent role in the maintenance of pruriceptors in adulthood. These findings support the role
of NTFs as regulators of histaminergic and histamine-independent itch.
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Introduction
Itch, or pruritus, is mediated primarily by small diameter primary afferents that innervate
the skin and mucosa [1]. Pruriceptive nerve endings exist in close proximity to keratinocytes,
dermal fibroblasts, and immune cells in the skin, which can release pruritogens, pro-inflammatory
mediators, and neurotrophic factors (NTFs) that directly modulate primary afferent responses and
receptor expression [1-7]. NGF and the GDNF family ligands (GFLs) regulate the development,
morphology, target innervation, and physiology of peptidergic and non-peptidergic sensory
neurons [8-12]. Previous studies indicate that a large proportion of neurons expressing pruritogen
receptors also express TrkA and Ret, the tyrosine kinase receptors activated by NGF and GFLs,
respectively [13-16]. NGF and the GFLs directly sensitize the transient receptor potential (TRP)
channels TRPV1 and TRPA1, and can increase their expression in primary afferents [17-21].
Histamine-evoked itch and sensory neuron responses are dependent on TRPV1 [20, 22, 23]. On
the other hand, itch evoked by chloroquine is functionally dependent on TRPA1 [19, 21, 22].
These findings suggest that neurotrophic growth factors may play an important role in regulating
normal and pathological itch.
Pruritic skin diseases are marked by epidermal hyperplasia and increased inflammatory
cell infiltration, which contribute to increased local levels of inflammation and NTFs. Studies of
patients with atopic dermatitis and psoriasis have demonstrated that the severity of itch correlates
with increased levels of nerve growth factor (NGF) in the skin and its receptor TrkA in epidermal
nerve fibers [24-27]. A recent study also found that artemin, a glial cell line-derived neurotrophic
factor (GDNF) family ligand, is increased in the skin of patients with atopic dermatitis [28]. In
addition, intradermal injection of NGF in human subjects enhanced itch produced by the nonhistaminergic pruritogen cowhage [29], while intravenous administration of artemin for the
treatment of sciatica resulted in frequent reports of pruritus [30, 31], further supporting a role for
NTFs in the modulation or generation of itch.
Neurotrophic factors are critical in the control of epidermal innervation, and epidermal
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hyperinnervation is another common feature of pruritic skin diseases [27, 32, 33]. Indeed, cultured
keratinocytes from patients with atopic dermatitis increased local NGF levels relative to healthy
keratinocytes and produced greater axon growth in co-cultures with porcine sensory neurons [34].
TrkA inhibition in a mouse model of atopic dermatitis reduced both dermatitis-associated
hyperinnervation and scratching behavior [35]. In addition, we recently found that the acetoneether-water model of dry skin itch is associated with epidermal hyperinnervation by Ret-positive
fibers [36], suggesting a role for both NGF and the GDNF family ligands (GFLs) in the regulation
of epidermal innervation in the context of itch.
In this study we investigated the roles of the major peripheral NTFs in regulating the
responses of sensory neurons to histamine and the histamine-independent pruritogen
chloroquine. Using a TrkA receptor mutant, we further investigated whether endogenous growth
factor signaling contributes to normal itch sensation and functional pruritogen receptor expression
in trigeminal ganglion neurons.

Materials and Methods
Animals
All experiments were conducted in accordance with the National Institutes of Health guidelines
and received the approval of the Animal Care and Use Committee of Washington University in
St. Louis, School of Medicine. Adult (8-12 week old) male littermate mice were housed on a 12
hour light-dark cycle and allowed ad libitum access to food and water. The effects of nerve growth
factor (NGF) and the GDNF family ligands GDNF, neurturin, and artemin on spontaneous and
pruritogen-induced scratching behavior were tested in C57BL/6 (Jackson lab) male littermates.
Heterozygous Ret-EGFP reporter animals were used to test the effects of neurotrophic factors on
pruritogen responses in vitro [10, 37]. Homozygous TrkAF592A mutants (a generous gift from Dr.
Wenqin Luo) and wild type littermates were obtained from heterozygous breeding pairs [38].
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Males aged 8 to 12 weeks were used for all behavior experiments. Males and females were used
for calcium imaging and immunohistochemistry experiments.

Pruritogen-induced scratching behavior
Because of the well-established role of NTFs in pain sensitization, the cheek assay was
used to differentiate between itch- and pain-specific effects of NTFs on behavioral responses to
pruritogens [39]. At least one day prior to the start of behavior experiments, the cheek skin was
shaved with electric clippers. On the day of experiment, animals were placed in individual
plexiglass observation chambers and allowed to acclimate in the presence of white noise for 2
hours. Using gentle restraint, animals were treated with a growth factor (0.2μg/10µl 0.9% normal
saline solution) or vehicle (0.9% normal saline solution) by direct intradermal injection into the
cheek skin using a 29½ gauge needle and 3/10cc insulin syringe. Neurotrophic growth factors
used were: Nerve Growth Factor (Harlan), and GDNF, neurturin, artemin (R&D Systems).
Behavioral responses were recorded immediately following injection using a video camera, and
scratching and wiping behavior was scored at a later time by observers blinded to treatment. A
single bout of scratching was defined as any number of individual scratch events separated by
licking or biting of the hind-limb, holding the limb motionless, or putting the limb down on the
surface. Wiping behavior indicating pain was defined as a rostrally-directed movement of the
ipsilateral forelimb across the cheek starting from the ear [39, 40]. One hour after pre-treatment,
animals were injected into the cheek skin with a pruritogen (histamine (1mg/10μl, Sigma) or
chloroquine (200µg/10µl, Sigma)). Pruritogen-induced scratching and wiping responses were
video recorded for 30 minutes immediately after injection and scored at a later time by observers
blinded to pre-treatment. The number of scratch bouts from both treatment and vehicle groups
were normalized to the vehicle mean for the day. For TrkA mutant experiments, 8-12 week old
TrkAF592A males and their wild type littermates were injected with histamine (500µg/10µl) or
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chloroquine (200µg/10µl). Behavior was recorded and scored at a later time by experimenters
that were blinded to mouse genotype.

Primary trigeminal ganglion cultures and calcium imaging
Experiments were performed using 8-12 week old Ret-EGFP reporter mice (C57BL/6)
obtained from Dr. Sanjay Jain [37]. For TrkA mutant experiments, 8-12 week old homozygous
TrkAF592A mutants and their wild type littermates were used. Animals were sacrificed by
decapitation and both trigeminal ganglia (TG) were carefully removed and cut into several pieces.
TG were incubated in papain (15U/ml) (Worthington, Lakewood, NJ) in Hank’s buffered saline
solution without Ca2+ or Mg2+ and with 10 mM HEPES at 37°C, 5% CO2 for 20 minutes. TG were
washed and then incubated in collagenase (1.5 mg/ml) for 20 minutes. TG were triturated with a
fire-polished Pasteur pipette, passed through a 40μm filter to separate large debris, and the
dissociated cells were plated on poly-D-lysine and collagen-coated glass coverslips. Cells were
cultured

overnight

in

Neurobasal

A

medium

supplemented

with

B27,

100U/mL

penicillin/streptomycin, 2 mM Glutamax, and 5% heat-inactivated fetal bovine serum (Gibco). No
additional growth factors were added to the media unless otherwise stated for specific
experiments. All calcium imaging recordings were performed within 24 hours of plating. For
experiments using Ret-EGFP animals, two animals were sacrificed per experiment and all four
trigeminal ganglia were pooled prior to plating the cells. Alternating coverslips were treated with
NTF (100ng/ml) or vehicle. At least two experiments (n=4 animals) were used per study. For TrkA
mutant experiments, TG from one mutant and one age-matched wild type littermate were cultured
simultaneously, but maintained separately.
The protocol for calcium imaging was adapted from our previous studies [41-44]. TG
neurons from Ret-EGFP mice were incubated for 45 minutes in 3 μg/mL (3µM) of the cellpermeant ratiometric calcium indicator Fura-2 AM (Molecular Probes) and then incubated in
external solution (in mM): 130 NaCl, 5 K, 2 CaCl2, 1 MgCl2, 30 Glucose, 10 HEPES for a 2081

minute de-esterification prior to recording. Coverslips were positioned in a recording chamber and
continuously perfused with external solution at room temperature. Cells were viewed using an
inverted microscope (Olympus Optical, Tokyo, Japan) and images were captured with a
Hamamatsu Orca camera. Regions of interest encompassing all Fura-2-loaded cells were
identified a priori and the ratio of fluorescence emission at an alternating excitation wavelength of
357 and 380 nm was recorded with SimplePCI Software. The experimental protocol consisted of
a 2-minute baseline measurement followed by bath application of the following stimuli
(concentration, application duration, source): histamine (100 μM, 30 seconds, Sigma, St. Louis),
chloroquine (1mM, 30 seconds, Sigma, St. Louis), capsaicin (200nM, 20 seconds, Sigma, St.
Louis), mustard oil (100µM, 30 seconds, Sigma, St. Louis). Each stimulus application was
followed by a wash with external solution for at least 8 minutes prior to subsequent stimulus
applications. All experiments were concluded with a 10 second application of 50mM KCl to identify
live neurons. Peak responses were determined by calculating the absolute increase in 357/380nm
emission ratio above baseline (the average fluorescence measured in the 30 seconds
immediately prior to stimulus application). A change from baseline ≥10% was set as the threshold
for a response. Cells that did not respond to KCl were excluded from physiological analysis. Prior
to recording, an image of EGFP-expressing neurons was captured. During data analysis, the
EGFP image was overlayed with the regions of interest from the recording to identify which
histamine- and chloroquine-responsive neurons were Ret-positive.

Heat, Mechanical, and Cold Thresholds
All behavioral experiments were completed between 8 AM and 6 PM. All animals were
individually tested in clear plexigalss observation boxes after a 2-hour acclimation period in the
presence of white noise. Experimenter was blinded to mouse genotype. Heat withdrawal latency
was determined using the Hargreaves assay (Model 390 Series 8, IITC Life Science Inc.)
performed on a glass plate maintained at 30°C [45]. Paw withdrawal latencies were determined
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using a radiant heat stimulus set at 15% active intensity and 3% inactive intensity. Stimulus cutoff was set to 20 seconds to avoid tissue injury. Five independent measurements were obtained
for each paw, and consecutive trials on the same paw were separated by at least 15 minutes.
To determine the 50% withdrawal threshold to mechanical stimuli, von Frey filaments were
applied using the up-down method [46]. Calibrated von Frey filaments (North Coast Medical) were
pressed against the hind paw skin between the anterior and posterior footpads until the filament
just bent. A response was counted when a mouse lifted its hind paw away from the applied
filament. Three trials were performed to determine the average withdrawal threshold (g) for each
animal.
Cold sensitivity was determined using the cold plantar assay [47]. Animals were
acclimated on top of a ¼ inch glass plate. Finely crushed dry ice was tightly packed into a modified
10 ml syringe to make a cold probe 1 cm in diameter. The cold probe was then applied to the
glass beneath the hind paw and withdrawal latency was measured with a stopwatch. Three trials
were conducted on each paw and consecutive trials to the same paw were separated by at least
15 minutes. Stimulus cut-off of 20 seconds was used to prevent tissue damage.

Immunohistochemistry
TrkAF592A homozygous mice and wild type littermates were deeply anesthetized (ketaminexylazine-acepromazine: 38-1.92-0.38 mg/mL; 2.7 mL/kg), footpad skin was removed, and animals
were perfused transcardially with phosphate-buffered saline followed by 4% paraformaldehyde
solution. Footpads were immersion-fixed in Zamboni’s fixative overnight, rinsed in PBS, and
cryoprotected in 30% sucrose. L4 DRG were dissected and cryoprotected in 30% sucrose. Tissue
was embedded in optimal cutting temperature (OCT) compound and flash frozen on dry ice.
Sections were cut on a cryostat at a width of 18µm (DRG) and 30 µm (footpad skin), and collected
on glass slides. For immunostaining, tissue was post-fixed on the slide in 4% PFA for 5 minutes,
washed with TBS, and blocked using 1% BSA and 0.05% TritonX-100. Sections were then
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incubated in primary antibody diluted in Tyramide Signal Amplification (TSA) reagent overnight at
4°C in a humidified chamber. Antibodies and dilutions used: rabbit anti-βIII tubulin (1:1000,
Covance), goat anti-CGRP (1:350-1000, AbD Serotec), Alexa Fluor 488/555 donkey anti-rabbit
(1:200-400, Invitrogen), Alexa Fluor 488 donkey anti-goat (1:200-350, Invitrogen). Slides were
sealed with ProLong Gold with DAPI (Molecular Probes).
Intraepidermal fiber density of the footpad skin was determined using previously described
methods [10, 48]. MetaMorph Software (Molecular Devices, Sunnyvale, CA) was used to measure
the length of the dermal-epidermal border. In each examined section, labeled fibers crossing the
dermal-epidermal border were counted on an upright epifluorescent microscope (Nikon 80i;
CoolSnapES camera). For each animal, six sections separated by >90µm were analyzed by a
blinded experimenter and the mean fiber density per animal was calculated. Representative
images of fibers stained with the above-described methods were obtained using a Leica SPE
Confocal microscope. Images were collected across the z-plane at 1µm width and maximum
projection images were generated using ImageJ software.

Statistical analyses
All statistical analyses were performed using GraphPad Prism 6.04 (2014). For
comparisons of scratching behavior, unpaired t-test was used to compare the total scratch bouts,
wipes, or normalized scratch bouts. For calcium imaging experiments, differences between the
proportion of responders in each treated group were determined using a χ2 test, where each cell
counted as an individual observation. Peak calcium increase in response to stimuli was analyzed
using unpaired t-test. For all statistical analyses, significance was defined at p<0.05. Data are
presented as mean ± S.E.M or overall proportion of responders (%).
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Results
Neurotrophic factors selectively modulate scratching responses to pruritogens
Acute administration of neurotrophic factors can directly sensitize noxious responses to
heat, cold, mechanical, and chemical stimuli [18, 49, 50]. To determine if neurotrophic factors can
also acutely potentiate scratching responses to pruritogens, NGF, GDNF, neurturin (NRTN), or
artemin (ARTN) were injected into the cheek skin of wild type mice. Scratching and wiping
behavior was recorded immediately after growth factor injection to determine the direct effects of
neurotrophic factors on spontaneous pain- and itch-specific behaviors. There were no significant
differences in scratching or wiping behavior between the vehicle- and neurotrophic factor-treated
groups, indicating that acutely administered NGF, GDNF, neurturin, or artemin alone do not
directly induce pain or itch (Figure 1). To determine the effects of neurotrophic factors on
histamine-dependent itch, one hour after NTF treatment all animals were injected with histamine

Figure 1. Neurotrophic factors do not induce spontaneous itch or pain. A. Scratch bouts
measured immediately after intradermal injection with neurotrophic factor (0.2µg/10µl) or
vehicle (10µl 0.9% NaCl) (N=6-8 animals/group, t-test, p=NS). B. Wipes were measured
immediately after NTF or vehicle injection.
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into the cheek skin. NGF pre-treatment significantly potentiated histamine-induced scratching
behavior (Figure 2A), but did not affect wiping. GDNF and neurturin administration did not affect
histamine-induced scratching or wiping (Figure 2B, C). Pre-treatment with artemin significantly
reduced histamine-induced scratching (Figure 2D), but did not affect wiping behavior. The effects
of neurotrophic growth factors on histamine-independent itch were determined using the
pruritogen chloroquine. One-hour pre-treatment with NGF, GDNF, and neurturin did not affect
scratching or wiping behavior induced by chloroquine (Figure 2E-G). On the other hand, artemin

Figure 2. Neurotrophic factors modulate scratching responses to pruritogens.
A. Histamine-induced scratching was potentiated by NGF pre-treatment. B-C. GDNF and
neurturin had no effect on histamine responses. D. Artemin pre-treatment reduced the total
scratch bouts evoked by histamine. E-G. Chloroquine-induced scratching was not changed
by NGF, GDNF, or neurturin. H. Artemin significantly potentiated chloroquine-evoked
scratching responses. (N=7-10 per group, t test, *p<0.05, **p<0.01)
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pre-treatment significantly potentiated chloroquine-induced scratching responses, with no effect
on wiping behavior (Figure 2 H). These findings indicate that acutely applied NGF and artemin
selectively modulate histaminergic and histamine-independent itch.

NGF and artemin directly modulate sensory neuron responses to pruritogens
To further investigate the mechanisms by which NGF and artemin potentiate itch, we used
ratiometric calcium imaging to study trigeminal sensory neuron responses to pruritogens in the
presence of these growth factors. A large proportion of chloroquine-responsive neurons express
MrgprA3 and represent a specific subset of primary afferents that express both the peptidergic
marker CGRP and the nonpeptidergic markers IB4 [13]. We utilized Ret-EGFP reporter mice to
better characterize Ret expression in the subsets of functionally-identified histamine- and
chloroquine-responsive neurons (Figure 3A-B).
The effects of NGF on histamine responses were measured after acute 1-hour incubation
or overnight incubation in NGF (100ng/ml) or vehicle. Because TRPV1 is activated downstream
of histamine receptor activation and plays a key role in histaminergic itch, responses to capsaicin
were also measured (Figure 3C). Of histamine-responsive neurons in the vehicle group, 80.3%
were Ret-positive (n=71 cells, Figure 3D). Acute, 1-hour pretreatment with NGF did not change
the total number of histamine-responsive neurons (N=78/482 vehicle cells (15.4%) vs. N=99/555
NGF-treated cells (17.8%), χ2 test, not significant) or the peak calcium responses to histamine
(Figure 3E). Similarly, 1-hour NGF did not change the proportion of capsaicin-responsive neurons
(N=53/193 (27.5%) vehicle neurons vs N=68/226 (30.1%) NGF-treated neurons, χ2 test, not
significant). Overnight incubation with NGF resulted in a significant increase in the proportion of
histamine-responsive neurons (N=43/477 (9.1%) vehicle neurons vs. N=89/620 (14.4%) NGFtreated neurons, χ2 test, p<0.01) (Figure 3F). There was no effect on peak calcium responses to
histamine.

Overnight

NGF

treatment

did
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not

change

the

overall

proportion

of

Figure 3. NGF increases the proportion of histamine-responsive neurons. A, B.
Representative images of Fura-2-labeled and Ret-EGFP-positive TG neurons. Arrows indicate
cells labeled by both markers. C. Representative traces of neurons treated tested for histamine
and capsaicin responses. D. Of histamine-responsive neurons (n=71), 80.3% were Ret+. E. 1hour pre-treatment with NGF did not affect the number or peak of histamine responses, or the
proportion of capsaicin responsive neurons. F. Overnight pre-treatment with NGF increased
the proportion of histamine-responsive neurons, but did not affect peak histamine responses
or total capsaicin responsive neurons (χ2 test, **p<0.01).
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capsaicin-responsive neurons. Neither treatment changed the proportion of histamine-responsive
neurons that also responded to capsaicin (1-hour: 96.9% veh vs. 92.7% NGF; overnight: 90.1%
veh vs. 87.6% NGF). These results indicate that acutely applied NGF does not affect the number
of histamine-responsive neurons in vitro. However, overnight exposure to NGF increased the
proportion of histamine-sensitive neurons, suggesting an expansion of histamine receptor
expression in previously histamine-unresponsive neurons.
To determine whether artemin directly modulates sensory neuron responses to the nonhistaminergic pruritogen
chloroquine, dissociated
TG

neurons

RetEGFP
animals

from
reporter

were

tested.

Responses to mustard oil
were

also

tested

to

determine

if

TRPA1

modulation

is

another

possible mechanism for
the

potentiation

of

chloroquine-induced itch
(Figure

4A).

In

vehicle-treated
83.0%
Figure 4. Artemin increases the proportion of CQ-responsive
neurons. A. Representative traces of neurons that were treated
tested for chloroquine (CQ) and mustard oil (MO) responses. B.
83% of chloroquine-responsive neurons were Ret-positive (n=93).
C, D. Both 1 hour (C) and overnight (D) pretreatment with artemin
(100ng/ml) significantly increased the proportion of chloroquineresponsive neurons (χ2 test, *p<0.05, ***p<0.001).
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of

the

the

group,
total

chloroquine-responsive
neurons

were

Ret-

positive

(Figure

4B).

Acute pre-treatment with

artemin for 1 hour resulted in a significant increase in the proportion of chloroquine-responsive
neurons from 10.9% in the vehicle group (N=104/956 cells) to 17.2% in the artemin-treated group
(N=131/762 cells, χ2 test, p<0.001) (Figure 4C). Artemin pre-treatment did not affect peak calcium
responses to chloroquine or the proportion of mustard oil-sensitive neurons (24.7% of vehicle- vs
23.5% of artemin-treated neurons, χ2 test, not significant). Overnight pre-treatment with artemin
likewise increased the proportion of chloroquine-responsive neurons (N=51/429 vehicle neurons
(11.9%) vs. N=84/508 artemin-treated neurons (16.5%), χ2 test, p<0.05), but did not change peak
responses to chloroquine or the proportion of mustard oil-responsive neurons (Figure 4D). Neither
treatment changed the proportion of chloroquine responders that also responded to mustard oil
(1-hour: 72.1% vs. 71.8%; overnight: 66.7% vs. 63.1%). These findings indicate that acute and
prolonged artemin pre-treatments significantly increase the proportion of chloroquine-responsive
neurons in vitro, which may contribute to the potentiation of chloroquine-induced itch behavior.

TrkAF592A mutation increases nociceptive detection thresholds but does not affect
pruritogen-induced scratching
To investigate whether endogenous NGF-TrkA signaling plays a role in regulating itch
sensation and pruriceptor physiology, we obtained TrkAF592A mutant animals. These animals have
a phenylalanine (F) to alanine (A) mutation in the ATP-binding pocket of TrkA that renders the
receptor sensitive to pharmacological inhibition by the small molecule kinase inhibitor 1NMPP1
[38]. We tested untreated homozygous mutants and their wild type littermates to confirm normal
baseline pain and itch sensation. TrkAF592A mutants did not differ from their wild type littermates
in body mass (n=4-5 per genotype, Figure 5A). However, homozygous TrkAF592A mutants with no
pharmacological treatment had significantly increased baseline heat withdrawal latencies
compared to their wild type littermates (N=7 per genotype, unpaired t test, *p<0.05) (Figure 5B).
TrkAF592A mutants also demonstrated decreased sensitivity to mechanical and cold stimuli (Figure
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5C-D). These results suggest that even without the use of pharmacological inhibitors, the
TrkAF592A mutation has effects on endogenous TrkA function. Despite the observed effects on
heat,

mechanical,

and

cold

detection

thresholds, histamine- and chloroquine-induced
scratching behavior was not different between
TrkAF592A mutants and their wild type littermates
(Figure 5E-F). These results indicate that the
TrkAF592A mutation alters baseline nociceptive
behaviors but does not affect pruritogen-evoked
itch.
NGF-TrkA signaling regulates sensory
neuron

survival

during

development

and

maintains target innervation and receptor
expression in adulthood. The observed changes
in pain detection thresholds may be due to loss
of intraepidermal nerve fiber density or sensory
neuron loss during development. To determine
whether the TrkAF592A mutation results in a
hypomorphic

receptor,

immunohistochemistry
Figure 5. TrkAF592A mutation increased
baseline heat, mechanical, and cold
thresholds, but did not affect histamineand CQ-evoked scratching responses.
Mutants demonstrate normal body weight
(A), but decreased nociceptive responses
(B-D). Histamine- and chloroquine-induced
itch was not different between genotypes (EF). (n=7 per genotype, unpaired t test,
*p<0.05, **p<0.01).

to

we

used

quantify

skin

innervation. There was a significant decrease in
βIII-tubulin immunoreactive epidermal nerve
fibers in the footpad skin of TrkAF592A mutants
when compared to wild type littermates,
indicating a loss of total intraepidermal fiber
density (Figure 6A-C). CGRP-positive fibers
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were also significantly decreased in the mutant group, indicating a substantial loss of peptidergic
innervation (Figure 6D-F).

Figure 6. Altered TrkA signaling results in peptidergic intraepidermal fiber loss, but
minor changes in sensory neuron responses to pruritoges and algogens. Representative
images of βIII-tubulin-labeled intraepidermal fibers in wild type (A) and mutant (B) footpad skin.
C. TrkAF592A mutants had a significant reduction on total intraepidermal fiber density (n=3-4
animals per group, t test, **p<0.01). D-E. Representative images of CGRP+ fibers in wild type
(D) and mutant (E), demonstrate the significant reduction in peptidergic fibers (F, n=3-4
animals per group, t test, **p<0.01). Calcium imaging studies show a reduction in the
proportion of histamine (G) and capsaicin (J) responders, but no effect on chloroquine- or
mustard oil-responsive neurons (H-I) (χ2 test, *p<0.05, **p<0.01).
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To determine whether altered NGF-TrkA signaling in the TrkAF592A mutant contributes to
changes in pruriceptor and nociceptor subpopulations, we tested trigeminal neuron
responses to the pruritogens histamine and chloroquine, and the algogens mustard oil
and capsaicin. Despite the lack of behavioral effects on histamine-induced scratching, our
data indicate a significant decrease in the overall proportion of histamine-responsive
neurons from 13.3% to 9.1% in mutant animals (N=145/1089 +/+ neurons; N=78/853
TrkAF592A neurons, χ2 test, p<0.01) (Figure 6G). There were no differences in the
proportion of chloroquine- and mustard oil-responsive neurons (Figure 6H-I). TrkAF592A
mutation resulted in a small but significant decrease in the proportion of capsaicinresponsive neurons (N=270/819 (24.8%) wild type neurons versus N=172/681 (20.2%)
TrkAF592A neurons, χ2 test, p<0.05) (Figure 6J). These findings indicate the TrkAF592A
mutation likely alters endogenous TrkA signaling, resulting in a substantial loss of
peripheral target innervation. Population studies using calcium imaging suggest that
histamine- and capsaicin-responsive subpopulations depend on TrkA activity, while
chloroquine- and mustard oil-responsive neurons may be maintained via TrkAindependent mechanisms.
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Discussion
Chronic pruritus is a tremendous clinical problem associated with a number of
dermatological diseases, including atopic dermatitis and psoriasis. Lesional skin in pruritic
conditions exhibits increased levels of growth factors and epidermal innervation [24-27],
suggesting that neurotrophic growth factors contribute to pruriceptor fiber growth and excitability.
Here we investigated the direct effects of NGF and the GDNF family ligands on pruritogen-evoked
itch behaviors and sensory neuron responses in vitro. Our data demonstrate distinct roles for NGF
and artemin in the modulation of histamine- and chloroquine-evoked itch, respectively. Using
TrkAF592A mutants, we tested the role of endogenous TrkA signaling in the maintenance of
pruriceptors in adulthood, and determined that pruriceptive neurons are likely supported by TrkAindependent mechanisms.
The role of NGF in nociceptor plasticity has been extensively studied [51], yet little is
known about the direct effects of NGF on pruriceptor physiology. Increased serum and skin levels
of NGF in atopic dermatitis, prurigo nodularis, and psoriasis, suggest a role for NGF-TrkA
signaling in the induction or maintenance of chronic pruritus [24-26, 52, 53]. Several studies have
demonstrated acute application of NGF induces thermal and mechanical hyperalgesia in both
rodents and humans [50, 51, 54-60]. One study tested the effects of a single intradermal injection
of NGF on pruritogen-induced itch in healthy human volunteers, and determined that there was a
potentiation of cowhage-induced itch, but not histamine-induced itch [29]. These results contrast
with our finding that acutely applied NGF selectively potentiated histaminergic itch in mice. One
factor that may contribute to this difference is the timeline of treatment. In the human study,
investigators tested pruritogen responses at days 7 and 21 after NGF treatment, in order to
coincide with previously identified peak of thermal and mechanical hyperalgesia, respectively.
The 1-hour time point applied in our study likely restricts the effects of NGF to local receptor
expression or sensitization at the fiber terminals, but it does not provide enough time for broad
transcriptional or fiber growth changes to take place in trigeminal neurons [61]. The effects of
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NGF treatment in humans one hour after intradermal injection remain unknown, but our findings
suggest that acute sensitization of histamine-responsive fibers could occur.
To investigate the direct effects of NGF on pruriceptive neurons and identify a potential
mechanism for the sensitization observed in vivo, we measured dissociated trigeminal neuron
calcium responses to histamine after treatment with NGF. Overnight incubation with NGF resulted
in a significant increase in the number of histamine-responsive neurons, but acute 1-hour
treatment had no effect. The lack of acute effect observed in culture suggests that NGF-induced
sensitization of histamine-evoked itch may be dependent on NGF activation of local inflammatory
cells such as mast cells to release mediators that can directly activate or sensitize afferent fibers
innervating the skin [62, 63]. The expansion of the histamine-responsive proportion of neurons
with prolonged overnight treatment suggests that NGF is a transcriptional regulator of histamine
receptors in neurons and can induce expression in neurons that were previously histamineinsensitive. Unexpectedly, NGF pre-treatment did not alter the proportion of capsaicin-responsive
neurons, despite its well-known contribution to TRPV1 expression and sensitization. In summary,
our data indicate that NGF increases histamine receptor expression in sensory neurons,
suggesting that NGF may be a transcriptional regulator for receptors involved in itch, as well as
pain.
Studies have demonstrated that GFLs can also induce hyperalgesia by direct sensitization
of nociceptors and modulation of nociceptor phenotypes. Acutely, all three GFLs sensitize TRPV1
to produce thermal hyperalgesia. Inflammation and neuropathy models demonstrate that artemin
and its co-receptor GFRα3 are upregulated and mediate cold hyperalgesia [49, 64] . On a more
chronic scale, overexpression studies show that artemin increases both the expression of TRPV1
and TRPA1 and intraepidermal fiber innervation, which contribute to increased sensitivity to heat,
cold, and chemical stimuli [17, 65].
We determined the effects of the GNDF family ligands (GFLs) GDNF, neurturin, and
artemin on pruritogen-evoked itch. Our findings indicate that GNDF and neurturin do not affect
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pruritogen-evoked itch, while artemin potentiates chloroquine-induced itch but suppresses
histamine responses. To activate the receptor tyrosine kinase Ret, each GFL requires a specific
co-receptor known as the GDNF receptor α (GFRα1-4), conferring GFL-cell type specificity [8].
MrgprA3-positive neurons represent a subset of the chloroquine-responsive population, and
molecular studies using reporter mice demonstrate that this group of cells expresses both the
peptidergic marker CGRP, and the non-peptidergic marker Ret [13, 66]. Our calcium imaging
studies in Ret-EGFP reporter mice indicate the vast majority of functionally identified chloroquinesensitive neurons are indeed Ret-positive. The artemin co-receptor GFRα3 is also found in
sensory neurons that express Ret, TrkA, and peptidergic markers such as TRPV1 and CGRP [49,
65, 67], suggesting that MrgprA3 and GFRα3 may colocalize to the same population.
Furthermore, artemin was previously demonstrated to enhance warmth-induced “itch-like”
grooming responses in mice [28], and clinical trials testing artemin as a potential treatment for
sciatica found the most commonly reported adverse effect (occurring in more than 40% of
participants) was pruritus [30, 31]. These findings support the idea that artemin can acutely
sensitize itch responses to non-histaminergic pruritogens. Furthermore, our calcium imaging
studies demonstrate that artemin increased the proportion of chloroquine-responsive neurons in
culture, indicating artemin may also be a transcriptional regulator of chloroquine receptor
expression.
To determine the role of endogenous TrkA signaling in the maintenance of pruriceptors in
adulthood, we used the TrkAF592A mutant. Despite no reports of a detrimental effect on neuronal
survival in the early postnatal period [38], we found that the TrkAF592A mutation resulted in
significant intraepidermal fiber loss and increased pain detection thresholds in adulthood. These
findings are consistent with the analgesic phenotypes of NGF/TrkA knock-out animals [68, 69],
suggesting that this mutation alters normal TrkA signaling and likely results in a hypomorphic
receptor. Interestingly, pruritogen-evoked itch and sensory neuron responses in these animals
remained largely intact. In vitro studies of sensory neurons demonstrate a small but significant
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reduction in the proportion of histamine- and capsaicin-responsive neurons. Prior studies have
demonstrated the proportion of histamine-responsive neurons can range between approximately
10-15%, which may explain why this reduction did not result in robust in vivo effects. These
findings suggest that endogenous NGF-TrkA signaling may not be required for the maintenance
of pruriceptive fiber innervation and functional pruritogen receptor expression in adult sensory
neurons. However, further characterization of sensory neuron loss and receptor activation is need
to clarify the extent functional loss in these mutants.
In summary, we tested the hypothesis that neurotrophic factors regulate pruritogeninduced itch and sensory neuron responses. We found NGF and artemin have distinct roles in
the sensitization of histaminergic and histamine-independent itch. In addition, NGF and artemin
regulate pruritogen receptor expression in vitro, suggesting a potential mechanism for itch
sensitization in pruritic skin diseases where high levels of growth factors can be found in the skin.
Furthermore, a mutation in the high-affinity NGF receptor TrkA confirms its involvement in
nociceptor maintenance, but indicates it may not be required for normal itch responses.
Neurotrophic growth factors represent potential clinically relevant mediators of itch and further
studies should explore their role in chronic and inflammatory itch mechanisms.
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Chapter 5
Functional studies of human sensory neuron responses to pruritogens

This chapter is adapted from the following manuscripts:
Valtcheva MV*, Copits BA*, Davidson S, Sheahan TD, Pullen MY, McCall JG, Dikranian K,
Gereau RW. Surgical extraction of dorsal root ganglia from organ donors and preparation of
primary human sensory neuron cultures. Nature Protocols. 2016. In Press.
Valtcheva MV, Golden JP, Sheahan TD, Pullen MY, Vogt SK, Jain S, Davidson S, Gereau RW.
Neurotrophic factors selectively modulate pruritogen responses in mouse but not human sensory
neurons. 2016. In Preparation.
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Abstract
Primary cultures of rodent sensory neurons are widely used to investigate the cellular and
molecular mechanisms involved in pain and itch. The translation of preclinical findings into
effective patient therapies may be greatly improved by direct validation in human tissues. We
developed an approach to extract and culture human sensory neurons in collaboration with a local
organ procurement organization. Here we describe the surgical procedure for extraction of human
dorsal root ganglia (hDRG) and the culture techniques used to prepare viable adult human
sensory neurons for functional studies. Dissociated sensory neurons can be maintained in culture
for more than 10 days, and are amenable to electrophysiological recording and calcium imaging.
We further applied this approach to determine the effects of growth factors on human pruriceptor
populations. Our findings indicate that NGF and artemin did not change the proportion of
pruriceptive neurons, suggesting different mechanisms may be involved in the sensitization of
mouse versus human sensory neurons. The approach we have developed can be applied at any
institution with access to organ donors that consent to tissue donation for research and provides
an invaluable resource for improving translational research.
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Introduction
Preclinical studies of pain, itch, nerve injury, regeneration, and axonal transport rely
heavily on the use of primary cultures of dissociated rodent sensory neurons. Many candidate
molecular targets and genes have been identified using this approach, yet few of these findings
have directly translated into effective and safe clinical treatments [1-5]. Several notable failures in
translation have raised questions about possible differences in fundamental biological
mechanisms between humans and rodents [6-12]. For example, NK1 receptor antagonists failed
to provide significant analgesia in humans, despite strong preclinical effects in rodents [6]. In
addition, GABAA receptor-mediated currents in cultured human sensory neurons were recently
found to exhibit distinct biophysical features from those in rodents, demonstrating the importance
of preclinical validation between species [13-16].
Recent advances in induced pluripotent stem cell (iPSC) methods have produced
nociceptor-like cells derived from human fibroblasts that express TRP channels and can be
sensitized by inflammatory mediators such as PGE2 [17, 18]. Unlike sensory neurons obtained
from organ donors, such methods are not restricted by donor availability because they do not rely
on post-mortem tissue collection and can be further strengthened by a living donor’s developing
medical history. However, the iPSC approach is still significantly limited by low nociceptor
conversion rates (<5%) and the use of varying transcription factor combinations to produce
nociceptor-like populations. While both approaches can be informative, direct studies in human
sensory neurons may more accurately recapitulate the complex overlapping sensory neuron
subpopulations and downstream signaling cascades involved in sensory processing.
Cultured human sensory neurons can serve as a valuable tool in functional and genetic
studies to validate the numerous molecular targets identified in animal models. By using
techniques such as patch-clamp electrophysiology, calcium imaging, immunohistochemistry,
gene knock-down, and viral gene transfer, the fundamental physiological properties of human
sensory neurons can be more accurately characterized. These approaches could lead to the
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discovery of novel target receptors or channels and allow for in-depth characterization of
pharmacological agents in native human cells. Furthermore, the potential of novel therapeutic
interventions involving gene therapies, and optogenetic and chemogenetic manipulations of
cellular activity can be verified directly in human sensory neurons. The protocol we developed
allows us to obtain DRG from multiple spinal levels, giving us the opportunity to culture from half
of

the

ganglia,

while

preserving

the

remaining

tissue

for

RNA

sequencing

and

immunohistochemical analysis. This permits parallel functional and gene expression studies from
the same donor with the ability to correlate observations with patient medical record information
[14, 16, 19]. Future studies employing a combination of these approaches can help identify human
biomarkers for chronic pain and itch.
Recent studies in the field of itch have identified the Mas-related G protein-coupled
receptor (Mrgpr) subtypes A3 and C11 as key mediators of acute and chronic itch in mice [2022]. However, these receptors are not evolutionarily conserved in humans, which instead have
four MRGPRX receptors (MRGPRX1-4). Studies using heterologous systems have determined
that the human MRGPRX1 receptor can be activated by both MrgprA3 and MrgprC11 agonists,
although key differences in the pharmacological and signaling profiles of these receptors indicate
distinct molecular mechanisms in mice versus humans [20-24]. In this study, we demonstrate the
pruriceptive subpopulations of human sensory neurons that respond to histamine and
chloroquine, and their functional overlap with TRP channels. In our prior studies we determined
that NGF and artemin increased the proportion of histamine- and chlroquine-responsive neurons
in mouse. We now test the effects of these growth factors in human sensory neurons and use
RNA sequencing to determine the expression of pruritogen receptors, TRP channels, and
neurotrophic growth factor receptors in whole human DRG.
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Materials and Methods
Access to human donor tissue
We established a collaboration with Mid-America Transplant, a local organ procurement
organization. Extraction procedures were approved by Mid-America Transplant and appropriate
regulatory documentation and agreements were obtained, including IRB waiver from the Human
Research Protection Office at Washington University in St. Louis and material transfer agreement.
Mid-America Transplant obtained documentation of donor or family consent to tissue donation for
research and provided access to all medical records available at procurement. Since establishing
this approach at our institution, we have had access to donor tissue approximately 1-2 times per
month. Once a donor becomes available and consent has been obtained for tissue donation to
research, we are contacted by Mid-America Transplant staff, generally 3-8 hours prior to organ
procurement.

Surgical extraction of human dorsal root ganglia (hDRG)
Sterile operating room procedures were followed throughout tissue extraction in order to
not interfere with further tissue procurement after DRG have been removed. Once the transplant
surgical team completed the extraction of all organs to be used for transplantation (e.g. liver,
kidneys, heart), all remaining viscera were either retracted or removed. The lumbar spinal column
was exposed by removing the abdominal vasculature, including the abdominal aorta, inferior vena
cava, and lymphatics, and remaining connective tissue located anterior to the spine in the
retroperitoneal space. The psoas major and psoas minor muscles were cut and retracted or
removed from their origin to expose the lateral aspects of the spinal column and the roots of the
lumbar plexus. Using a mallet and straight osteotome, L1 and L5 vertebral bodies were
transected, stopping at the spinal canal (Figure 1a). With the use of a mallet and curved
osteotomes, the pedicles were transected bilaterally between L1 and L5, while staying close to
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Figure 1. Surgical extraction of hDRG using ventral approach. (a-b) Illustration depicting
the ventral (a) and lateral (b) views of the spinal column with lumbar vertebral bodies L1 and
L5 indicated by arrows. Red dashed lines indicate the location of bone transection. After the
spinal column is visualized, lumbar vertebrae can be correctly identified by counting up from
L5, which is located directly above the sacrum (a,b). Using a straight osteotome and surgical
mallet, the L1 and L5 vertebral bodies are transected, stopping at the spinal canal (red dashed
lines in panel a, black lines indicate transected bone in panel b). Using a curved osteotome
and mallet or autopsy saw, the pedicles of each vertebrae are transected bilaterally between
L1 and L5 (red dashed lines in panel b). (c) Illustration showing the anterior portion of the
vertebral column removed to expose the spinal canal where the cauda equina and DRG are
located (TP: transverse process, CE: cauda equina, PLL: posterior longitudinal ligament, DM:
dura mater, DRG: dorsal root ganglion). (d) Each DRG is dissected away from surrounding
bone and connective tissue and the nerve roots and rami are cut to completely free each
ganglion (red dashed lines).
the posterior edge of the vertebral bodies, but anterior to the spinal canal (Figure 1b). The entire
anterior portion of the vertebral column between L1 and L5 was manually removed by lifting
carefully to minimize tearing of structures in the intervertebral foramina and simultaneously cutting
any dural attachments to the posterior longitudinal ligament (Figure 1c). This approach ensured
that the transverse processes, laminae, and spinous processes remain in place. It is essential to
leave the dorsal portion of the vertebral column intact to maintain the integrity of the body for
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further tissue procurement and funeral service purposes. When devising our approach, this was
a major concern for Mid-America Transplant.
DRG were visualized by a gentle tug on the dura mater and each ganglion was dissected
away from surrounding connective tissue and bone using DeBakey pick-ups and dissecting
scissors. The spinal roots and rami of peripheral nerves were then cut to completely free the DRG
(Fig. 1d). Each DRG was fully submerged in ice-cold N-methyl-D-glucamine artificial
cerebrospinal fluid solution (NMDG-aCSF) in air-tight 50 ml conical tubes and maintained on ice
for transport. NMDG-based aCSF solutions reduce neuronal permeability to sodium and calcium,
reduce oxidative stress, and are very beneficial for producing adult rodent brain and spinal cord
slices for electrophysiological recordings [25-28]. DRG tissue from human organ donors was
extracted as soon as possible to minimize post-mortem interval. We were generally able to extract
DRG 1.5-3 hours post-mortem, immediately after the surgical resection of organs for
transplantation. However, we have obtained viable neuron cultures from tissues extracted up to
4 hours post-mortem.

Cleaning and dissection of DRG
Upon return to the laboratory, each individual DRG was placed in a 60 mm petri dish filled
with ice cold NMDG-aCSF and maintained on ice for the duration of cleaning and dissection.
Using large spring scissors and forceps, any remaining fat and connective tissue surrounding
DRG were removed (Figure 2a). With the aid of a dissection microscope, forceps and large spring
scissors were used to identify the edge of the dura along the severed ends of the central and
peripheral nerve processes. The dura was then cut longitudinally from the peripheral to the central
endings. The dura was removed by continually pulling away from the ganglion and cutting along
the edge where the dura meets the DRG and nerves (Figure 2b). The remaining central and
peripheral nerve processes were trimmed with a scalpel, so that only the ganglion body remained

109

Figure 2. Cleaning of hDRG prior to dissociation. (a) Extracted ganglia are first cleaned of
all visible fat and connective tissue. (b) Dura mater is then removed to expose underlying
ganglion and nerve roots and rami. (c) Nerve roots are trimmed so that only the ganglion
remains for dissociation. Scale bars represent 1 cm.
(Figure 2c). One ganglion from each spinal level was used for culture, while the corresponding
contralateral DRG was saved for immunohistochemistry and RNA sequencing studies, to allow
for direct functional comparisons. Once the contralateral ganglion was cleaned, it was cut into
small pieces and part of the tissue was immediately frozen in RNAlater for RNA sequencing or
RT-PCR, while the rest of the DRG was post-fixed in 4% paraformaldehyde solution for intact
ganglion histology.

Dissociation and culturing of DRG
Each DRG to be used for culture was minced with a scalpel as finely as possible into
pieces no larger than 3 mm in diameter. All tissue fragments were placed into a 14 ml snap-cap
tube containing 3 ml of pre-warmed (37°C) papain/NMDG-aCSF solution (1.5U/ml) and incubated
for 1 hour at 37°C and 5% CO2. The tube was gently agitated every 20 min to mix tissue with
solution. The tissue was washed carefully 3 times with 3 ml of fresh NMDG-aCSF, warmed to
37°C. The tissue was then incubated in 3 ml of NMDG-aCSF-collagenase (15mg/ml) solution for
1 hour at 37°C and 5% CO2, while agitating gently every 20 min to mix the tissue with the solution.
Tissue was carefully washed 3 times with 3 ml of fresh NMDG-aCSF warmed to 37°C. The
remainder of NMDG-aCSF solution was then removed and 2 ml of pre-warmed DRG medium
were added. DRG tissue was then triturated gently through the fire-polished tip of a sterile glass
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Pasteur pipette until the solution became cloudy and little resistance remained (approximately 1020 times). The solution of dissociated neurons was carefully passed through a 100 μm sterile filter
into a 50 ml conical tube. The filtrate was centrifuged at room temperature for 4 min at 180g. The
supernatant containing debris was carefully removed and the pellet was re-suspended in 1 ml
warmed DRG medium by pipetting up and down several times. Cell suspension was centrifuged
again for 3 min at 180g. The supernatant was removed and the pellet was re-suspended in 1 ml
warmed DRG medium by mixing gently. At this point, the cell suspension was counted using a
hemocytometer and diluted to desired concentration. The cell suspension was plated onto polyD-lysine and collagen-coated glass coverslips for a final plating density of approximately 500
cells/coverslip. The cell-plated coverslips were incubated at 37°C, 5% CO2 for 1-1.5 hours to allow
neurons to adhere to the glass and then 900 μl warm DRG medium was added. Dissociated
hDRG cultures were maintained at 37°C, 5% CO2 in a humidified chamber until use. Half of the
culture medium was replaced with fresh warmed medium every 3-4 days.

Reagents
Poly-D-lysine (PDK) solution was made by dissolving 5 mg PDK in 50 ml sterile water,
aliquoted into 1 ml (0.1 mg/ml) per tube, and stored at -20°C. Rat tail collagen (Sigma) was
dissolved in sterile water for a final concentration of 1 mg/ml and stored at 4°C up to 2-3 months.
PDK/collagen solution was made at a final concentration of 0.01 mg/ml PDK and 0.2 mg/ml
collagen. Papain solution was made by adding 0.5 μl of 0.5 M NaOH to 1 mg/50μl L-cysteine and
then combined with 45U papain in 3 ml of NMDG-aCSF. Solution was made fresh and warmed
to 37°C immediately prior to use. DRG medium was Neurobasal A media supplemented with B27,
100U/mL penicillin/streptomycin, 2 mM Glutamax, and 5% fetal bovine serum (Gibco). For
electrophysiology experiments, neurotrophic factor (NTF)-treated neurons were plated in the
presence of 25ng/ml human β-nerve growth factor (hNGF) (Cell Signaling Technology) and
recombinant human glial cell line-derived neurotrophic factor (hGDNF) (Peprotech).
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NMDG-artificial cerebrospinal fluid (aCSF) solution: The reagents listed in Table 1 were combined
in 450 ml Milli-Q H2O in the order listed. pH was adjusted to 7.4 with NMDG/HCl and osmolarity
was adjusted to 300-310 mOsm with H2O or sucrose [25, 26]. NMDG-aCSF solution was always
made fresh and bubbled with carbogen gas (95% O2, 5% CO2) for at least 15 min prior to use to
achieve stable pH and saturate with oxygen.
Table 1. Reagents used to prepare NMDG-aCSF.

Reagent
NMDG
HCl
KCl
NaH2PO4
NaHCO3
HEPES
Glucose
Ascorbic acid
Thiourea
Na+pyruvate
MgSO4
CaCl2
N-acetylcysteine

Final
Concentration
(mM)
93
2.5
1.25
30
20
25
5
2
3
10
0.5
12

MW or
Concentration
of stock
195.2
12.1 N
2.5 M
1.25 M
84.0
2M
2.5 M
176.1
76.1
110.0
2M
1M
163.2

500 ml
9.08 g
3.5 ml
500 μl
500 μl
1.26 g
5 ml
5 ml
0.44 g
0.08 g
0.17 g
2.5 ml
250 μl
0.98 g

Immunocytochemistry
Coverslips of dissociated neurons were fixed in 4% paraformaldehyde/ 4% sucrose.
Antibodies used include: Rabbit anti-TRPV1 (1:800), custom-made serum directed against the
TRPV1 C-terminus peptide CLKPEDAEVFKDSMVPGEK, specificity confirmed in TRPV1-/- mice
[29, 30]; Mouse anti-βIII-tubulin (1:2000) – EMD Millipore (cat. no. 05-559), species reactivity
(hm/bv/rat/ms), Antibody Registry ID: AB_309804; Guinea pig anti-GFAP (1:1000) – Synaptic
Systems (cat. no. 173 004), species reactivity (hm/rat/ms/ck), Antibody Registry ID:
AB_1064116;. Mouse anti-synapsin 1 (1:2000) – Synaptic Systems (cat. no. 106 001), species
reactivity (hm/ms/rat/avian/zebrafish), Antibody Registry ID: AB_887805; Guinea pig anti-tau
(1:2000) – Synaptic Systems (cat. no. 314 004), species reactivity (hm/ms/rat), Antibody Registry
ID: AB_1547385. Secondary antibodies used were donkey Alexa Fluor 555/647 (1:2000).
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Patch-clamp Electrophysiology
Fire polished, filamented glass electrodes were pulled using a P-97 horizontal puller
(Sutter Instrument Company) with open tip resistances ranging from 2.0–4.5 MΩ. The internal
pipette solution contained (in mM): 120 K+ gluconate, 5 NaCl, 2 MgCl2, 0.1 CaCl2, 10 HEPES,
1.1 EGTA, 4 Na2ATP, 0.4 Na2GTP, 15 sodium phosphocreatine; pH adjusted to 7.3 using KOH,
osmolarity 291 mOsm. For the duration of recording, cells were continuously perfused with
external solution at room temperature containing (in mM): 145 NaCl, 3 KCl, 2.5 CaCl2, 1.2 MgCl2,
10 HEPES, 7 glucose, adjusted to pH 7.4 with NaOH. Neurons were recorded with an EPC10
amplifier (HEKA Instruments) and Patchmaster software (HEKA Instruments). After acquiring
gigaseal and break-in, neurons were given at least 2 minutes to stabilize and then a series of
protocols to determine membrane excitability were performed. Action potentials were evoked in
current clamp mode using a series of increasing 1 second ramp current injections. The first action
potential of a train was used to determine threshold, defined as the voltage at which the first
derivative of the membrane potential increased by 10 V/s. Rheobase was established from the
step or ramp current pulse at which the first action potential was triggered.

Calcium imaging
The protocol for calcium imaging was the same as our previous studies in mouse [29-33].
Neurons were incubated for 45 minutes in 3 μg/mL (3µM) of the cell-permeant ratiometric calcium
indicator Fura-2 AM (Molecular Probes) and then incubated in external solution (in mM): 130
NaCl, 5 K, 2 CaCl2, 1 MgCl2, 30 Glucose, 10 HEPES for a 20-minute de-esterification prior to
recording. Coverslips were positioned in a recording chamber and continuously perfused with
external solution. Recordings took place at room temperature. Cells were viewed under an
inverted microscope (Olympus Optical, Tokyo, Japan) and images were captured with a
Hamamatsu Orca camera. Regions of interest encompassing all Fura-loaded cells were identified
a priori and the ratio of fluorescence emission at an alternating excitation wavelength of 357 and
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380 nm was recorded with SimplePCI Software. The experimental protocol consisted of a 2minute baseline followed by 30 second bath application of 100 μM histamine (Sigma, St. Louis),
8 minutes of external solution wash, 30 seconds of 1mM chloroquine (CQ, Sigma, St. Louis), 8
minutes external solution wash, 30 seconds of 100 μM mustard oil (MO, Sigma, St. Louis), 8
minutes of external solution, 20 seconds of 200nM capsaicin (Sigma, St. Louis), 4-8 minutes of
external solution, and 10 seconds of high KCl (50mM). Peak responses were determined by
calculating the absolute increase in Fura-2 signal above baseline immediately prior to each
stimulus. A change from resting level of ≥10% was set as the threshold for a response to a bath
applied stimulus. Cells unresponsive to capsaicin or high K+ were excluded from physiological
analysis. Calcium imaging recordings were performed on the 5th-7th days in vitro (DIV) to allow
glial cells to peel off neurons and expose the plasma membrane for reliable Fura-2 signal
visualization. For NTF treatment, cells from the same donor were treated with growth factor
(100ng/ml human nerve growth factor, Peprotech; 100ng/ml human artemin, R&D Systems) or
vehicle the evening prior to recording. The overall proportion of responders were determined for
each donor and used for statistical comparisons (unpaired t test). Post-hoc measurements of cell
diameter of responsive neurons were made in ImageJ using images obtained immediately prior
to calcium imaging recording in SimplePCI.

RNA sequencing of whole human DRG
RNA and library preparation: Fresh DRG tissue from organ donors was cut into several sections
and frozen at -80°C in RNAlater (Ambion) immediately after extraction. For RNA preparation,
DRGs were thawed, cut into small pieces, and put in TRIzol reagent (Life Technologies Inc).
Tissue was then homogenized using an electric homogenizer and total RNA was isolated per the
manufacturer’s instructions. Only samples with RNA integrity number (RIN) of > 7 were used for
further analysis. Library preparation was done at the Genome Technology Access Center at
Washington University (GTAC). Briefly, 30 ng of total RNA were reverse transcribed and amplified
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using the SMARTer Ultra low input RNA for Illumina Sequencing –HV (Clontech). After cDNA
preparation and shearing using an ultra-sonicator (Covaris), the libraries were prepared using
VeraSeq Ultra DNA Polymerase for 12 cycles.

The forward primer used was:

AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT. The
reverse primer contains the unique reverse complement of the respective index nucleotides. The
sequence of the reverse primer where "N" denotes the reverse complement of 7 nucleotides of
the

index

is

CAAGCAGAAGACGGCATACGAGATNNNNNNNGTGACTGG-

AGTTCAGACGTGTGCTCTTCCGA. The purified cDNA yield was 16.5 ng/μl in 30μl.
Nextgeneration sequencing and analysis: Single end sequencing was done on the Illumina
HiSeq2500 platform following the manufacturer's protocol at the GTAC. The raw demultiplexed
RNA-seq

reads

were

aligned

with

STAR

version

2.0.4b

(https://github.com/alexdobin/STAR/releases) (GRCh37 assembly). Low base quality reads and
adaptors were clipped. All known genes with raw counts were enumerated to the matching gtf
file from the same reference build from Ensembl with Subread:featureCounts (version 1.4.5)
(http://sourceforge.net/projects/subread/) using the Ensembl gene ID as the key. Reads per
kilobase of transcript per million mapped reads (RPKM) values were generated in R using raw
counts. We assessed sequencing performance for total number of aligned reads, uniquely
aligned reads, number of genes and transcripts detected, and found less than 1% of ribosomal
fraction and Spearman correlation of >0.9 between samples.
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Results
Establishing primary cultures of human dorsal root ganglia
We developed a collaboration with the local organ procurement organization Mid-America
Transplant to gain access to human dorsal root ganglia from deceased organ donors that have
consented to tissue donation for research. After devising a surgical approach that provides a short
post-mortem interval and minimal interference with further tissue procurement (Figure 1), we were
able to obtain DRG from a number of donors of both sexes and varying ages (Table 2). We
established a culturing protocol which follows our prior published studies of mouse sensory
neurons very closely, utilizing the same coverslip coating solution, digestive enzymes, and culture
medium [30-32, 34-37]. However, we incorporated a number of key modifications: a specifically
designed preservation solution for transport, new instructions for tissue preparation, changes to
enzyme digestion duration, and amount of time in culture prior to functional recordings [30-32, 3437]. Our studies using hDRG show that these adaptations maintain neuronal viability in transport
and address several issues that arise from dissociation of substantially larger tissues with more
abundant connective tissue than rodent DRG [19].
Table 2. Donor demographics. (COD: cause of death, CVA: cerebrovascular accident).
Donor # Age Sex Race/Ethnicity COD
1 27
F
White
Head trauma
2 30
F
White
CVA/Stroke
3 31
F
White
Head trauma
4 44
F
Middle Eastern CVA/Stroke
5 58
F
White
CVA/Stroke
6 10
M
White
Head trauma
7 21
M
White
CVA/Stroke
8 22
M
Black
Anoxia
9 41
M
White
Head trauma
10 44
M
White
CVA/Stroke
11 47
M
White
Head trauma
The total number of coverslips obtained for functional studies depended on the number of
ganglia cultured and cell density needed for the particular study. We found that one DRG can
produce approximately 10-12 coverslips plated at a density of 500 cells/coverslip. However, this
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can vary based on several factors, including DRG size (L1 is considerably smaller than L2-4),
degree of dissociation, and general health of the tissue. Younger donors tended to have DRG
that were easier to dissociate and neuron number and responses in culture were generally better.
The density of 500 cells/coverslip provides an optimal number of cells for calcium imaging studies
(~20-30 cells per viewing field at a 10x magnification) without excessive debris. Future studies
can adjust the plating density to fit investigator needs. For example, plating at a lower density of
200 cells/coverslip was suitable for electrophysiological recordings and immunocytochemical
studies, but did not provide robust numbers for calcium imaging studies.

Figure 3. Dissociated hDRG neurons over time in vitro. Infra-red differential interference
contrast microscopy (IR-DIC) images of cultured human sensory neurons. (a) Initially, most
dissociated neurons are encased in glial cells (white arrows) after 1 day in vitro (DIV), but can
be identified by partially visible plasma membrane (white arrowhead). (b) As time in culture
progresses, glia (white arrows) continue to peel off and adhere to the coverslip, exposing more
of the plasma membrane. (c) After 6 DIV, the plasma membrane of most neurons is completely
exposed, leaving them amenable to patch-clamp recordings and calcium imaging studies.
Scale bars represent 20 μm.
Appearance of neurons in culture
While most rodent studies can be completed within 24 hours of cell plating, human sensory
neurons were often tightly encased by satellite glia until the third or fourth day in vitro (DIV). During
these first days in culture, glial cells peeled off allowing membrane access for patch pipettes or
direct fluorescence visualization (Figure 3). More vigorous dissociation protocols can yield
neurons free of supporting glia, but the health and survival of these neurons may be reduced [16].
The neurons produced with our extraction and dissociation protocol could be maintained in culture
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for more than 10 days. Whole ganglia and dissociated neurons can be studied using validated
antibodies and standard immunocytochemical techniques to characterize cell morphology and the
localization and expression of ion channels, receptors, and intracellular proteins (Figure 4) [28,
30]. In addition, the coverslips used for functional studies by patch-clamp [16, 36-38] and calcium
imaging [31, 36] can be fixed immediately after the experiment to allow for immunocytochemical
studies of the same functionally-characterized neurons.

Figure 4. Immunocytochemical analysis of cultured hDRG neurons. Collapsed confocal
micrographs of immunolabeled neurons using standard techniques. (a) GFAP+ cells (purple) presumably satellite glia that initially encase dissociated hDRG neurons – that have migrated
onto the coverslip after 8 DIV. (b) Merged image with neurons immunolabeled for the
cytoskeletal protein βIII-tubulin (green) and nuclei labeled with DAPI (blue). (c) TRPV1
immunofluorescence (red), a common nociceptive marker in rodent DRG, was observed in
subsets of cultured human sensory neurons. Nuclei are labeled with DAPI (blue). (d-f)
Fluorescence images of cultured hDRG demonstrating extensive axonal process growth and
branching marked by tau immunoreactivity (green) and a component of the synaptic vesicle
release machinery, synapsin (red). Merged images are shown in (f) with DAPI-labeled nuclei
(blue). (g-i) Cropped sections from the boxed areas in (d-f), showing an en passant-type
presynaptic enlargement (synapsin, red) that formed along a sensory axon (tau, green). Scale
bars represent 50 µm for panels (a-f), and 5 µm for the panels shown in (g-i).
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Electrophysiological properties of hDRG neurons cultured in the presence or absence of
growth factors
Prior studies using primary cultures of hDRG neurons have applied human nerve growth
factor (hNGF, 25 ng/mL), and human glial cell line-derived neurotrophic factor (hGDNF, 25 ng/mL)
in the culture medium [16]. However, growth factors can directly modulate neuronal excitability
and receptor expression, thus confounding any future studies on the effects of growth factors on
pruriceptor sensitization. To determine if culturing with or without growth factors significantly
impacted sensory neuron physiology, we used patch-clamp electrophysiology techniques to
measure the basic excitability and membrane properties of the neurons in our cultures. We found
that cells cultured without growth factors survive for more than 10 days without measurable effects
on membrane properties. Gigaohm seals were obtained from >95% of selected neurons. We were
careful to only patch neurons with a clearly visible soma devoid of satellite glial cells and exhibited
a “smooth” membrane (Figure 3c). Whole-cell recordings were successful from >95% of these
neurons, which included stable access resistance and a resting membrane potential
hyperpolarized over -40 mV. We found that neurons could be cultured in the absence or presence
of the growth factors NGF and GDNF, and that chronic treatment did not affect cellular excitability,
resting membrane potential, or soma size (Figure 5). The ability to maintain these neurons in
culture in the absence of growth factors allows for future studies to determine the acute effects of
growth factors on receptor expression and neuronal sensitization.

Effects of NGF and artemin on human pruriceptors
Very little is currently known about the human pruriceptive sensory neuron populations
and whether they can be sensitized by neurotrophic factors. To investigate the direct effects of
neurotrophic factors on dissociated hDRG neurons, we measured calcium responses to the
pruritogens histamine and chloroquine, the TRPA1 agonist mustard oil, and the TRPV1 agonist
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Figure 5. Long-term culturing with neurotrophic factors does not alter hDRG
excitability.
Human sensory neurons were grown in the absence (black traces) or presence (red traces)
of the neurotrophic factors NGF and GDNF (NTFs, 25ng/ml each, added to wells chosen
randomly from all spinal levels). Recordings were performed between 4-9 DIV and cells were
excluded from further analysis if the resting membrane potential was more depolarized than
-40 mV. (a,b) Voltage traces illustrating action potential firing to 1 s depolarizing step (a) or
ramp (b) current injections of 1-4 times current threshold (rheobase) of neurons grown in the
absence (black traces) or presence of NTFs (red traces). Scale bars are 20 mV and 200 ms.
(c,d) Summary plots of the number of action potentials elicited in neurons in response to
both step (c) and ramp (d) stimuli, which were not significantly different between the two
culturing conditions (two-tailed Mann-Whitney test, P values range from 0.143 to 0.964). (e,f)
Quantification of step (e) or ramp (f) current threshold to elicit an action potential. No
differences were found between the two groups (two-tailed Mann-Whitney test, P=0.738 for
panel e, and P=0.361 for panel f). (g) Summary graph of the resting membrane potential for
cells cultured in the absence or presence of NTFs, which were not significantly different (twotailed unpaired t-test; P=0.657). (h) Average soma diameters of neurons in both culturing
conditions, which were not significantly different (two-tailed unpaired t-test; P=0.775). This
suggests that the preferential survival of sub-populations of sensory neurons with different
cell diameters was not influenced by either culturing condition. 19-30 cells were used for
quantification per condition from four donors (4-30 cells for each measurement per donor),
and all data are represented by the mean ± s.e.m of cells pooled across all donors.

capsaicin. Prior to recording, neurons were maintained in culture without growth factors for 5-7
days. Due to the precious nature of human tissue, we focused our studies on the growth factors
we previously determined had effects on mouse pruriceptors: NGF and artemin. Once free of glial
cells, neurons were treated with either a growth factor or vehicle overnight. On the next day,
neurons were incubated with the fluorescent calcium indicator Fura-2AM and calcium responses
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Figure 6. Effects of NTFs on human sensory neuron responses to pruritogens. A.
Calcium responses of dissociated hDRG neurons were measured using Fura-2AM (scale
bar=100µm). B. Representative traces of calcium responses to the indicated bath-applied
stimuli. C. Frequency histogram of cell diameter of responsive neurons. D. Distribution of
stimulus-responsive neurons in control groups across all donors. Each data point represents
an individual donor. E. Overnight treatment with NGF (100ng/ml) did not change the proportion
of histamine-, chloroquine-, or capsaicin-responsive hDRG neurons (N=3 donors, 9-86
cells/donor). F. Pretreatment with artemin (ARTN, 100ng/ml) did not affect the overall
proportion of responsive neurons (N=3 donors, 10-42 cells/donor, unpaired t test).
to bath applied stimuli were recorded (Figure 6A-B). The average soma diameter of vehicletreated neurons in culture was 45 µm (± 9.9 µm SD, minimum: 16.8 µm, maximum 72.6 µm,
n=118 neurons) (Figure 6C).
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We determined the relative distribution of pruritogen- and algogen-responsive neurons in
our donor pool by calculating the proportion of vehicle-treated cells that responded to a given
stimulus for each individual hDRG donor (n=6-8 donors) (Figure 6D).

To asses if human

pruritogen receptors colocalize with TRP channels, we determined the proportion of neurons that
responded to more than one stimulus (Table 3). Our data demonstrate that 87% of all histamineresponsive neurons also responded to capsaicin, indicating that most histamine-sensitive
neurons are also TRPV1-positive. More than half of histamine responders also responded to
chloroquine, while only a third of chloroquine-sensitive neurons responded to histamine. and more
than half also responded to chloroquine (Table 1). Chloroquine-responsive neurons were largely
TRPV1-positive (74%), but more than half also responded to mustard oil. Most TRPA1-positive
neurons responded to chloroquine, but few also responded to histamine or capsaicin. Overnight
pre-treatment with NGF or artemin did not change the proportion of neurons that responded to
histamine, chloroquine, mustard oil, or capsaicin (Figure 6E-F). These data indicate that the
expression of human pruritogen receptors was not significantly affected by growth factor
treatment, suggesting that the mechanisms behind NTF regulation of itch-sensitive neurons differ
between mouse and human.
Table 3. Functionally overlapping subpopulations of human sensory neurons.
% Responding to another stimulus
Histamine CQ
MO
Capsaicin
Histamine+
56.00% 27.74% 87.27%
Total
CQ+
36.84%
53.85% 73.68%
responsive
MO+
15.63%
65.62%
36.84%
neurons
Capsaicin+ 40.00%
51.85% 24.14%

RNA sequencing was used to quantify transcripts encoding pruritogen receptors, TRP
channels, and neurotrophic factor receptors in whole human DRG. Transcriptome data were
obtained from 5 donors, and confirm the presence of histamine receptor 1 (HRH1) and 2 (HRH2)
transcripts, but none of the subtypes 3 and 4 (HRH3, HRH4) (Figure 7). Sequencing data further
demonstrate the presence of MRGPRX1, the putative ortholog of the mouse MrgprA3/C11
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pruritogen receptors. Interestingly, there was also a considerable amount of MRGPRX3
transcripts detected, however, very little is known currently about the physiological role of
MRGPRX3. Despite the high proportion of capsaicin-responsive neurons identified in our
functional studies, TRPV1 transcript levels in whole DRG tissue were surprisingly low. TRPA1
RNA was clearly detectable, though levels were not as high as the pruritogen receptor levels.
Transcripts for the neurotrophic factor receptors TrkA (NTRK1) and Ret were detected, in addition
to the GFRα 1-3 co-receptors. Consistent with prior mouse studies which demonstrate no role for
persephin-GFRα4 signaling in sensory neurons, RNA sequencing found no GFRα4 transcripts in
human DRG.

Figure 7. Expression of pruritogen receptors, TRP channels, and growth factor receptor
transcripts in hDRG. RPKM values were averaged across individual donors (N=5). Data are
presented as mean ± s.e.m.
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Discussion
Several recent studies have identified species differences and validated molecular
mechanisms using human sensory neurons, but few have provided a detailed description of
extraction or culturing methodologies [13-16]. Here, we provide a detailed surgical extraction
protocol for post-mortem access to human dorsal root ganglia (hDRG) immediately after organ
procurement from consented donors. We demonstrate a culturing protocol that yields primary
neurons that are amenable to a variety of functional approaches. In addition, we demonstrate that
maintaining adult sensory neurons in culture without growth factors did not have a significant
effect on their basic electrophysiological properties. We then demonstrate the distribution of
pruriceptive and nociceptive populations in human DRG did not change in the presence of NGF
or artemin. Future applications of this protocol have the potential to significantly impact our
understanding of human neurophysiology and provide a platform for better translational studies
of itch and pain mechanisms.
The extraction protocol we present here addresses several key issues that organ
procurement organizations (OPOs) are likely to be concerned with when negotiating a research
collaboration. The ventral surgical approach through the abdominal cavity eliminates the need to
move the donor during the procedure and preserves structural integrity of the body, thus
significantly reducing post-mortem interval for DRG retrieval and resulting in minimal interference
with other surgical procedures. Maintaining a sterile intraoperative field during the extraction
allows subsequent tissue procurement of bone and skin, ensuring maximal utilization of donor
tissues by the OPO. Importantly, this approach maintains the overall integrity of the donor body
for funeral purposes, allowing access to all who consent to tissue donation for research without
being restricted to donors who opt for cremation.
Recent publications indicate that it may also be possible to culture human sensory
neurons in the presence of other types of culture media [13, 14, 16]. Investigators may decide to
incorporate the same enzymatic digestion, plating protocol, or culture media they have previously
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used in animal model studies if the goal is to make direct comparisons to those prior studies. In
such cases, this protocol can provide a positive control to confirm the viability of neurons as
investigators adopt the extraction and dissection procedures in their own laboratories. Notable
differences between our protocol and those previously described include the specific types of
enzymes used (papain versus trypsin and DNase [13], or proprietary enzyme mixture [14, 16])
and the duration of enzymatic digestion (up to 3.5 hours in some studies). The type of culture
medium and use of neurotrophic factors has also varied between studies, with several utilizing
DMEM/F12-based media and all studies supplementing with varying concentrations of NGF
and/or GDNF. The successful culturing of human cells in a variety of different culture media and
following different digestion methodologies suggests that individual labs may be able to adapt this
protocol. Producing viable cultures of adult human sensory neurons using conditions similar to
those used in previous studies of rodent neurons should reduce sources of variation and allow for
more direct comparison between rodent and human sensory neurons.
Previous studies demonstrate that NGF and artemin are increased in the lesional skin of
patients with pruritic diseases [39-44]. In addition, in chapter 4, we demonstrated that NGF and
artemin can increase the proportion of histamine- and chlorquine-sensitive neurons. To determine
if the same mechanism exists in human sensory neurons, we tested neuronal calcium responses
to pruritogens and algogens after incubation with NGF or artemin. Our data demonstrate that
overnight pre-treatment with either NTF did not alter the proportion of histamine- or chloroquineresponsive neurons. There was also no change in the proportion of capsaicin and mustard oil
responders. Several factors may contribute to the observed differences between mouse and
human responses to NTF treatment. The time spent in culture is longer in human experiments
because it was necessary to wait for the glial cells to expose the plasma membrane of neurons
to allow reliable calcium imaging recordings. Time in culture can be associated with transcriptional
changes that could be a major contributor to the observed differences between mouse and human
neurons. Future studies can address this by recording responses in mouse neurons that were
125

maintained in culture for longer. Alternatively, our results may simply indicate that human and
mouse pruriceptive neurons are not modulated by NGF and artemin via the same mechanisms.
Sequencing data from whole DRG tissue obtained from the same donors that provided
neurons for functional studies confirm the presence of pruritogen and neurotrophic growth factor
receptors. The detection of MRGPRX1 transcripts in hDRG and direct activation of sensory
neurons by chloroquine strongly suggest a functional role for MRGPRX1 in human sensory
neuron physiology. Despite activation by the same group of agonists, MRGPRX1 is not a true
ortholog of the mouse MrgprA3 or MrgprC11 receptors. In heterologous systems, these receptors
may engage different downstream mechanisms such as activation of different TRP channels
(TRPV1 versus TRPA1) [23]. These fundamental differences in receptor signaling may contribute
to the differences we observed in NTF responses of mouse versus human chloroquine-sensitive
neurons.
To our knowledge, this study is the first to apply ratiometric calcium imaging in dissociated
human DRG cultures to characterize the human subpopulations that respond to pruritogens. The
proportion of pruritogen- and algogen-responsive sensory neurons varied across donors, with
histamine- and chloroquine-responsive neurons encompassing a larger proportion than what is
generally reported in rodents. Most pruriceptive neurons responded to capsaicin, suggesting the
possibility of a functional link between pruriceptor GPCR signaling and TRPV1. Future studies
utilizing pharmacological interventions such as QX-314 and TRPV1 antagonists could directly test
this hypothesis. The specific culturing protocol we have described can produce live adult sensory
neurons that are amenable to physiological and biochemical measures and are similar to those
studied in our previous publications [16, 19]. Dissociated cultures of human sensory neurons are
a valuable resource that enables the precise manipulation of external factors to study neuronal
physiology specific to humans and can strengthen future studies of itch and pain mechanisms.
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Chapter 6
Conclusions and Future Directions
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The work presented in this dissertation applies a multifaceted approach to address key
questions about the molecular mechanisms that underlie the neurobiology of acute and chronic
itch. In chapter 2, we utilized global genetic knock outs and acute pharmacological inhibition to
characterize the contribution of PKCδ to acute histamine-induced itch. We applied the AEW model
of dry skin itch to investigate the anatomical and functional changes associated with persistent
itch in chapter 3. Our work identified the specific subset of Ret-positive fibers as likely contributors
to dry skin-induced pruritus. In chapter 4 we investigated the effects of neurotrophic factors on
pruriceptive responses, and found distinct roles for NGF and artemin the sensitization of
histamine-dependent and -independent itch. Finally, in chapter 5 we demonstrated a novel
method for the extraction and successful culturing of human sensory neurons, allowing us to
perform the first studies to functionally characterize the pruriceptive subpopulations in humans.

PKCδ as an intracellular mediator of itch
In chapter 2, we investigated the role of the specific PKC isoform PKCδ in acute
pruritogen-induced itch. Our studies indicate that PKCδ contributes to histamine-evoked
scratching behavior, but may be dispensable for non-histaminergic itch induced by the pruritogens
chloroquine and β-alanine. In the peripheral nervous system, PKCδ expression was restricted to
small diameter sensory neurons, and was found in both peptidergic and nonpeptidergic neurons.
Physiological studies of cultured adult DRG using genetic and pharmacological tools demonstrate
that PKCδ mediates histamine-induced responses of sensory neurons. In addition, PKCδ may act
downstream of the histamine receptor to modulate TRPV1 activity, as there was a significant
reduction in capsaicin responses after histamine application. We conclude that PKCδ is involved
in the sensory neuron responses that mediate acute histaminergic itch.
Several questions remain about the precise role of PKCδ in histamine-induced itch. First,
it is not clear whether PKCδ is engaged directly downstream of histamine receptor signaling or if
it plays a more constant modulatory role in modulating or engaging downstream effector proteins
132

such as TRPV1. Future studies could determine if PKCδ is engaged downstream of histamine
receptor activation by studying PKCδ translocation to the membrane. This assay has been
validated previously, and can be further strengthened by the use of a PKCδ-KO-validated
antibody [1]. The lack of reliable histamine receptor antibody availability can be overcome by
combining calcium imaging measurements to identify histamine-responsive neurons with
immunocytochemistry to probe for PKCδ translocation at specific time points after histamine
activation.
Previous findings from our lab showed that PKCδ deletion had no effect on acute pain,
but significantly reduced CFA-induced inflammatory heat hyperalgesia, suggesting a potential
function for PKCδ in nociceptor sensitization [2]. The expression of PKCδ in half of TRPV1positive neurons certainly suggests that it could be a modulator of TRPV1 expression or function.
In addition, PKCδ may be involved downstream of PGE2, NGF, and IL-6 signaling [3-6]. Indeed,
NGF-induced ERK phosphorylation was inhibited by the PKCδ pharmacological inhibitor rottlerin
[5]. PKCδ has also been implicated in sickle cell-associated pain, paclitaxel-induced hyperalgesia,
and NGF-TrkA induced axon growth in osteoarthritis [7-9]. Future studies could investigate
whether there is indeed a functional link between PKCδ and inflammation-induced sensitization
of TRPV1. Furthermore, PKCδ deletion could be tested in the context of inflammatory itch models
such as dry skin and allergic contact dermatitis.
Our studies demonstrate that despite a significant reduction in histamine-evoked itch,
histamine responses were not completely inhibited, indicating that a substantial number of
histamine-responsive neurons remain functional. This suggests other PKCδ-independent
mechanisms also contribute to the signaling of histaminergic itch. These findings support the idea
that the histamine-responsive population of sensory neurons is a heterogeneous group of cells,
and distinct mechanisms may mediate downstream activation of histamine-dependent signaling
cascades. This may be further reflected by the involvement of several histamine receptor
subtypes, including H4R, whose role in histamine-induced itch is not clearly defined yet.
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PKC activation is a key step in numerous signaling cascades, and several PKC isoforms
have been identified in sensory neurons. However, isoform-specific effects on itch and pain
remain poorly understood. A number of recent studies demonstrate inflammatory pain is mediated
by PKCε, but this is one of the first studies to address the role of a specific PKC isoform in itch
[10-19]. Ultimately, because of their extensive expression throughout the body, pharmacological
inhibition of PKC isoforms may not provide an optimal approach to treating chronic pain or itch.
However, by further dissecting the specific pathways associated with these kinases, we may be
able to identify a downstream target that is more specific and amenable to clinical translation.

Pruriceptor changes associated with models of chronic itch
The work presented in chapter 3 demonstrates the specific anatomical and functional
changes that are associated with a model of dry skin itch. Dry skin treatment resulted in a
significant increase in scratching, but not wiping behavior, indicating that it elicits an itch-specific
phenotype. The resulting intraepidermal hyperinnervation was independent of scratching, and
included mostly Ret-positive non-peptidergic fibers. Interestingly, there were no changes in basic
membrane excitability properties of trigeminal neurons that innervated the treated skin. However,
there was an increase in the proportion of chloroquine-responsive trigeminal neurons, indicating
de novo expression of pruritogen receptors resulting in an expansion of the pruritic subpopulation
of sensory neurons.
The acetone-ether-water (AEW) model is widely used as a model of chronic itch, because
it shares several key characteristics with pruritic skin conditions. The skin changes observed in
this model include epidermal hyperplasia, parakeratosis, and spongiosis, which are also
frequently observed in the lesional skin of patients with atopic dermatitis and psoriasis. Barrier
dysfunction is another key feature of this model that is also associated with pruritic skin diseases
[20]. However, like xerosis in humans, the dry skin model is not marked by inflammatory
infiltration, which is a common feature in most chronic itch conditions. A major question remains
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regarding whether Ret+ fibers are also mediators of inflammatory itch. Inflammatory models of
chronic itch include ovalbumin hypersensitivity resembling allergic itch, MC903/Vitamin D3 analog
treatment which results in an atopic dermatitis-like phenotype, and trinitrochlorobenzene-induced
contact dermatitis [21]. Future studies can utilize existing reporter lines such as RetEGFP or
MrgprA3-TdTomato, to examine changes in pruritogen receptor expression and physiology under
different types of inflammatory itch. These models may also allow a more chronic time scale to
be applied, in order to determine the effects of long-term itch (>1-2 weeks) on pruriceptor plasticity
and innervation. Identifying the distinct mechanisms or subpopulations of pruriceptors that
mediate distinct types of itch could greatly aid in the development of more specific treatments by
minimizing the side effects that frequently result from systemic immunomodulatory treatments.
The “itch-scratch cycle” in chronic pruritic conditions is a vicious loop that results in further
inflammation and damage to the skin, thereby eliciting even more itch, anxiety, and frustration in
patients. The use of Elizabethan collars allowed us to block the pro-inflammatory effects of
scratching in order to determine the intrinsic changes that result from the induction of dry skin.
Interestingly, epidermal hyperplasia and hyperinnervation still occurred, despite lack of
mechanical stimulation and injury at the skin. This suggests that transepidermal water loss directly
contributes to the pathological changes observed in the dry skin model, and it is these epidermal
changes that likely drive the anatomical and functional effects associated with dry skin itch.

Neurotrophic factors and their effects on itch
In chapter 4, we examined the direct effects of neurotrophic factors on itch sensation and
pruriceptor physiology. We found that acutely administered neurotrophic factors do not induce
spontaneous itch or pain. Nerve growth factor (NGF) pretreatment selectively potentiated
histamine-induced itch, but did not affect chloroquine-evoked scratching responses. On the other
hand, artemin pretreatment potentiated chloroquine-induced itch, but appeared to inhibit
histamine responses. Our data suggest distinct roles for NGF and artemin in the modulation of
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histamine-dependent and histamine-independent itch. To further examine the mechanisms by
which these growth factors sensitized pruritogen-induced itch, we tested the effects of NGF and
artemin on histamine- and chloroquine- induced calcium responses. Acute 1-hour pre-treatment
with NGF did not affect the proportion of histamine-responsive neurons. On the other hand,
prolonged overnight incubation significantly increased the proportion of histamine responders,
indicating that NGF likely induces de novo expression of histamine receptors in sensory neurons.
Artemin increased the proportion of chloroquine-responsive neurons after both acute and
overnight pre-treatment. These results indicate that neurotrophic growth factors can sensitize itch
responses by upregulating the expression of pruritogen receptors via different mechanisms.
Further studies are needed to determine the effects of artemin on histamine responses.
Neurotrophic growth factors have long been studied as modulators of pain and several findings
indicate NGF and artemin can directly sensitize TRPV1 function and upregulate its expression.
Future studies can further dissect the downstream pathways underlying NGF- and artemininduced sensitization of itch [22]. A better understanding of NTF modulation of pruriceptive
responses will ultimately further our understanding of the distinct neurbiological mechanisms that
mediate itch versus pain.
A second major concept addressed in the studies presented in Chapter 4 is the role of
endogenous growth factor signaling in the maintenance of pruriceptors. In characterizing the
TrkAF592A mutant, we determined that this single point mutation most likely results in aberrant TrkA
receptor function. TrkAF592A mutants share several characteristics with TrkA/NGF knock-out
phenotypes, including significant hypoalgesia and profound loss of peptidergic intraepidermal
fiber innervation [23-26]. However, unlike the full loss of NGF/TrkA signaling, TrkAF592A animals
survived well into adulthood and appeared to be less severely affected. This suggests that the
TrkAF592A receptor is most likely hypomorphic, with enough residual function to support the
survival of some sensory neurons. Perhaps the most interesting finding from this study is the lack
of physiological effect on pruritogen-evoked scratching. In addition, calcium imaging studies
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demonstrate histamine- and chloroquine-sensitive neurons are still present in TrkAF592A mutants.
These results suggest that pruriceptor innervation and receptor expression may not be fully
dependent on TrkA/NGF signaling. Further studies are needed to fully characterize which sensory
populations are lost in order to begin to understand the loss of function in the TrkAF592A receptor.
This study raises another interesting question regarding the dual expression of
neurotrophic factor receptors in itch-sensitive neurons. If TrkA signaling is not important for the
maintenance of pruriceptive neurons, the next obvious candidate is the receptor tyrosine kinase
Ret, which regulates non-peptidergic neurons. Most Mrgpr family of receptors express Ret [27],
and the MrgprA3-positive subset of pruriceptors is marked by the expression of both TrkA and
Ret [28, 29]. Future studies can conditionally delete Ret in sensory neurons either acutely or
during development [30], by taking advantage of the numerous available Cre-recombinase lines.
A more specific role in pruriceptor function could be addressed by deleting Ret in MrgprA3positive neurons under the control of MrgprA3-Cre [28]. Furthermore, Ret deletion could be
combined with TrkA deletion (TrkAF592A animals also harbor LoxP sites at the TrkA locus), to avoid
neurotrophic factor receptor redundancy or compensation. The GFRα-GFL complex associates
with Ret to induce phosphorylation of key Ret tyrosine residues, which then serve as docking sites
for adaptor proteins such as Src, PLCγ, and Shc to activate downstream signaling cascades
including the PI3K and MAPK [31]. Specific Ret tyrosine mutants could be studied to delineate
whether specific downstream signaling mechanisms are involved in the maintenance versus
sensitization of pruriceptor populations [32].
The work presented in chapter 4 addressed the effects of acutely applied neurotrophic
growth factors on histamine- and chloroquine-induced itch. However, as mentioned previously,
there are a number of other acute and chronic itch models that can be applied in order to study
the role of neurotrophic factors and their receptors in the development or maintenance of chronic
pruritus [21]. Understanding the effects of neurotrophic factors on neurophysiology is becoming
an even more pressing issue as clinical trials using growth factors or growth factor-modulating
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compounds are well underway for the treatment of a number of diseases, including sciatica,
osteoarthritis, and Parkinson’s disease [33-38]. It is critical that we understand the wide range of
effects of neurotrophic factors in order to inform future studies of the potential for clinically relevant
adverse effects of new therapies.

Human sensory neurons: a key step toward translation
In chapter 5, we described a protocol we developed for the surgical extraction of human
dorsal root ganglia (hDRG) from deceased organ donors. By applying a few key modifications to
our mouse sensory neuron culturing protocol, we were able to dissociate and successfully culture
adult human sensory neurons. These neurons could be maintained in culture for over 10 days
and were amenable to several approaches including immunocytochemistry, RNA sequencing,
and even patch-clamp electrophysiology and calcium imaging. The work on this project
contributes tremendously to the field of pain and itch, by providing investigators with the means
to generate human primary sensory neuron cultures. Many research institutions are located within
or affiliated with a local medical center, where organ donation and transplantation takes place on
a frequent basis. By providing a clear road map for the extraction process, other researchers
could establish their own collaborations with local organ procurement organizations that will grant
them access to donor tissue donated for research. Expanding preclinical access to human tissues
has the potential to greatly improve the translation of preclinical findings into clinically effective
treatments. Furthermore, the validation of key findings in target tissues will save tremendous
amounts time and money.
Once we established that culturing without growth factors did not affect the basic
electrophysiological properties of human neurons, we proceeded to determine whether we could
observe the same effects of NGF and artemin on pruritogen-induced responses in vitro. Very few
studies have been able to study functional responses of human sensory neurons, and to our
knowledge, this is one of the first to characterize the human pruriceptive populations of cultured
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hDRG [39-46]. Our findings demonstrate the proportion of histamine-, chloroquine-, mustard oil-,
and capsaicin-responsive neurons and characterize the degree of overlap between these
functional receptors. The application of NGF and artemin did not change the overall proportion of
responsive human neurons, which contrasts with our observations in mouse neurons in chapter
4. It is possible that the mechanisms of pruriceptor sensitization by neurotrophic factors are
fundamentally different between species. However, it is also possible that there are inherent
differences between the cultures due to the absolute age of human versus mouse neurons or the
difference in time in vitro prior to recording secondary to the significant glial encapsulation of
human neurons.
The protocol we have established for extraction and culturing of human DRG has opened
the door to a number of exciting clinically relevant future studies and has resulted in several
collaborations with research groups across the country. The extraction procedure itself has
allowed us to also obtain spinal cord and intervertebral disc tissue. Future studies can begin to
address key questions about the sensitization of nociceptors by intervertebral disc tissue, which
can secrete pro-inflammatory cytokines and growth factors that are implicated in chronic low back
pain. Spinal cord tissue can be used to investigate the sensory neuron inputs into the dorsal horn
while serving as a model for studying synaptic transmission in humans.
We have only begun to characterize the physiology of human sensory neurons. Future
studies can start to validate or discover mechanisms behind sensory neuron sensitization by
direct treatment with growth factors or other clinically relevant inflammatory compounds [46]. Cocultures using peripheral tissues such as keratinocytes can be used to build in vitro models of
disease states to investigate the interactions between sensory neurons and their target tissues.
Furthermore, advances in RNA sequencing technologies could allow for the full genomic
characterization of the heterogeneous subsets of sensory neurons in human and determine how
they differ from model organisms [29]. Transcriptome sequencing techniques can be combined
with functional approaches such as calcium imaging and patch-clamp electrophysiology to identify
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the transcriptional profiles of functionally-identified subsets of neurons. In conclusion, access to
human neurons provides a vast number of opportunities to study normal and pathological neural
processing, and will be an invaluable tool for the validation and generation of novel treatments.
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Research Experiences
Doctoral Research
2012-2016, Washington University in St. Louis, St. Louis, MO
Neurosciences Program, Medical Scientist Training Program
Adviser: Robert Gereau, IV, Ph.D., Department of Anesthesiology and Washington University
Pain Center
Dissertation: Molecular Mediators of Acute and Chronic Itch in Mouse and Human Sensory
Neurons
Laboratory rotations
Tamara Hershey, Ph.D., Neuroimaging Laboratories, Neurology, June-August 2010
Beau Ances, M.D., Ph.D., Neuroimaging Laboratories, Neurology, April-June 2011
Robert Baloh, M.D., Ph.D., Neurology, June 2011
Undergraduate Research
Clinical and Cognitive Neuroscience Lab
University of Georgia, August 2007-May 2010
Jennifer McDowell, Ph.D., Department of Psychology
Honors Thesis: Neural Activation Differences in a Model of Cognitive Control: an fMRI
Study of Good and Poor Performers During Saccade Tasks
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Biomedical Research Apprenticeship Program (BiomedRAP)
Washington University in St. Louis, School of Medicine, June-August 2009
Karen O'Malley, Ph.D., Department of Anatomy and Neurobiology
Center for Undergraduate Research Opportunities (CURO) Summer Research Fellowship
University of Georgia, June-August 2008
Jennifer McDowell, Ph.D., Department of Psychology
Teaching Experience
Teaching Assistant – Cell and Organ Systems Physiology
Washington University in St. Louis, School of Medicine, 2012
Neuroscience Outreach, St. Louis University High School, 2013, 2015
Leadership
Graduate Student Representative, Neurosciences Program Steering Committee, May 2013present
Saturday Neighborhood Health Clinic, Co-Coordinator, May 2011-May 2012
Undergraduate Neuroscience Organization (UNO), Co-founder;
Vice President, October 2008-May 2010;
Treasurer, October 2008-October 2009
Phi Sigma Pi, National Honor Fraternity
Historian, May 2009-May 2010;
Alumni Chair, May 2008-May 2009;
Initiate Class Vice President, January-April 2008
Work and Volunteer Experience
Mercy Health Center, Athens, GA, Volunteer Interpreter, September 2009 – May 2010
St. Mary's Hospital Emergency Department, Athens, GA, Volunteer, May - December 2008
Starbucks Barista, February – September 2006
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